View Filing Data

Shares issued for stock options

121

153

Shares issued for restricted stock awards

(60)

Treasury stock acquired

(2,020)

Preference stock conversion

(169)

(813)

982

Ending Balance at Dec. 31, 2010

(2)

733

1,132

(99)

(11,305)

14,329

(2,115)

142

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

2,554

^[1]

2,431

123

Other comprehensive income, net of tax

(367)

(360)

(7)

Dividends declared:

Common stock

(1,111)

(92)

Shares issued for stock options

122

251

Shares issued for restricted stock awards

(53)

Treasury stock acquired

(1,806)

Ending Balance at Dec. 31, 2011

(1)

2,541

733

1,336

(60)

(12,808)

15,649

(2,475)

166

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

2,631

^[2]

2,472

159

Other comprehensive income, net of tax

(144)

(146)

Dividends declared:

Common stock

(1,168)

(109)

Shares issued for stock options

120

297

Shares issued for restricted stock awards

(70)

Treasury stock acquired

(1,943)

Ending Balance at Dec. 31, 2012

(2)

(17)

$ 2,390

$ 0

$ 733

$ 1,551

$ (41)

$ (14,386)

$ 16,953

$ (2,621)

$ 201

[1]

[2]

Consolidated Statements of Cash Flows - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Operating Activities

Net Income including noncontrolling interests

$ 2,631

^[1]

$ 2,554

^[2]

$ 2,313

Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:

Depreciation and amortization

425

421

376

Restructuring and termination benefits, net of cash

103

Venezuela hyperinflationary transition charge

271

Gain before tax on sales of non-core product lines

(207)

(50)

Voluntary benefit plan contributions

(101)

(178)

(35)

Accounts payable and other accruals

120

122

121

Deferred income taxes

Cash effects of changes in:

Receivables

(130)

Inventories

(21)

(130)

(10)

(5)

199

(65)

Other non-current assets and liabilities

135

Net cash provided by operations

3,196

2,896

3,211

Investing Activities

Capital expenditures

(565)

(537)

(550)

Sale of property and non-core product lines

263

Purchases of marketable securities and investments

(545)

(356)

(308)

Proceeds from sale of marketable securities and investments

147

423

167

Payment for acquisitions, net of cash acquired

(29)

(966)

Net cash used in investing activities

(40)

(9)

(865)

(1,213)

(658)

Financing Activities

Principal payments on debt

(5,011)

(4,429)

(4,719)

Proceeds from issuance of debt

5,452

5,843

5,015

Dividends paid

(1,277)

(1,203)

(1,142)

Purchases of treasury shares

(1,943)

(1,806)

(2,020)

Proceeds from exercise of stock options and excess tax benefits

478

353

242

Net Cash Provided by (Used in) Financing Activities

(2,301)

(1,242)

(2,624)

Effect of exchange rate changes on Cash and cash equivalents

(24)

(53)

(39)

Net increase (decrease) in Cash and cash equivalents

388

(110)

Cash and Cash Equivalents at beginning of the period

878

490

600

Cash and Cash Equivalents at end of the period

884

878

490

Supplemental Cash Flow Information

Income taxes paid

1,280

1,007

1,123

Interest Paid

$ 77

$ 58

$ 70

[1]

[2]

Nature of Operations

12 Months Ended

Dec. 31, 2012

Nature of Operations

The Company manufactures and markets a wide variety of products in the U.S. and around the world in two distinct product segments: Oral, Personal and Home Care; and Pet Nutrition. Oral, Personal and Home Care products include toothpaste, toothbrushes and mouth rinses, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, laundry and dishwashing detergents, fabric conditioners, household cleaners, bleaches and other similar items. These products are sold primarily to retail trade customers and wholesale distributors worldwide. Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The principal customers for Pet Nutrition products are specialty pet retailers and veterinarians. Principal global and regional trademarks include Colgate, Palmolive, Mennen, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, elmex, Tom’s of Maine, Sanex, Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet.

The Company’s principal classes of products accounted for the following percentages of worldwide Net sales for the past three years:



	2012		2011		2010
Oral Care	44	%	43	%	43	%
Personal Care	22	%	22	%	22	%
Home Care	21	%	22	%	22	%
Pet Nutrition	13	%	13	%	13	%
Total	100	%	100	%	100	%

Summary of Significant Accounting Policies	12 Months Ended
Summary of Significant Accounting Policies	Dec. 31, 2012
Notes to Financial Statements [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Principles of Consolidation The Consolidated Financial Statements include the accounts of Colgate-Palmolive Company and its majority-owned or controlled subsidiaries. Intercompany transactions and balances have been eliminated. The Company’s investments in consumer products companies with interests ranging between 20% and 50%, where the Company has significant influence over the investee, are accounted for using the equity method. Net income (loss) from such investments is recorded in Other (income) expense, net in the Consolidated Statements of Income. As of December 31, 2012 and 2011, equity method investments included in Other assets in the Consolidated Balance Sheets were $25 and $20, respectively. Unrelated third parties hold the remaining ownership interests in these investments. Investments with less than a 20% interest are accounted for using the cost method. Use of Estimates The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to use judgment and make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. As such, the most significant uncertainty in the Company’s assumptions and estimates involved in preparing the financial statements includes pension and other retiree benefit cost assumptions, stock-based compensation, asset impairment, uncertain tax positions, tax valuation allowances and legal and other contingency reserves. Additionally, the Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments and retirement plan assets. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. Actual results could ultimately differ from those estimates. Revenue Recognition Sales are recorded at the time products are shipped to trade customers and when risk of ownership transfers. Net sales reflect units shipped at selling list prices reduced by sales returns and the cost of current and continuing promotional programs. Current promotional programs, such as product listing allowances and co-operative advertising arrangements, are recorded in the period incurred. Continuing promotional programs are predominantly consumer coupons and volume-based sales incentive arrangements with trade customers. The redemption cost of consumer coupons is based on historical redemption experience and is recorded when coupons are distributed. Volume-based incentives offered to trade customers are based on the estimated cost of the program and are recorded as products are sold. Shipping and Handling Costs Shipping and handling costs are classified as Selling, general and administrative expenses and were $1,262, $1,250 and $1,142 for the years ended December 31, 2012, 2011 and 2010, respectively. Marketing Costs The Company markets its products through advertising and other promotional activities. Advertising costs are included in Selling, general and administrative expenses and are expensed as incurred. Certain consumer and trade promotional programs, such as consumer coupons, are recorded as a reduction of sales. Cash and Cash Equivalents The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Inventories Inventories are stated at the lower of cost or market. The cost of approximately 80% of inventories is determined using the first-in, first-out (FIFO) method. The cost of all other inventories, predominantly in the U.S. and Mexico, is determined using the last-in, first-out (LIFO) method. Property, Plant and Equipment Land, buildings and machinery and equipment are stated at cost. Depreciation is provided, primarily using the straight-line method, over estimated useful lives ranging from 3 to 15 years for machinery and equipment and up to 40 years for buildings. Depreciation attributable to manufacturing operations is included in Cost of sales. The remaining component of depreciation is included in Selling, general and administrative expenses. Goodwill and Other Intangibles Goodwill and indefinite life intangible assets, such as the Company’s global brands, are subject to impairment tests at least annually. These tests were performed and did not result in an impairment charge. Other intangible assets with finite lives, such as local brands and trademarks, customer relationships and non-compete agreements, are amortized over their useful lives, generally ranging from 5 to 40 years. Amortization expense related to intangible assets is included in Other (income) expense, net, which is included in Operating profit. Income Taxes The provision for income taxes is determined using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized based upon the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates that will be in effect at the time such differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Provision is made currently for taxes payable on remittances of overseas earnings; no provision is made for taxes on overseas retained earnings that are deemed to be permanently reinvested. The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return. The Company recognizes interest expense and penalties related to unrecognized tax benefits within income tax expense. Financial Instruments Derivative instruments are recorded as assets and liabilities at estimated fair value based on available market information. The Company’s derivative instruments that qualify for hedge accounting are designated as either fair value hedges, cash flow hedges or net investment hedges. For fair value hedges, changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, are recognized in earnings each period. For cash flow hedges, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) and are recognized in earnings when the offsetting effect of the hedged item is also recognized in earnings. For hedges of the net investment in foreign subsidiaries, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) to offset the change in the value of the net investment being hedged. Cash flows related to hedges are classified in the same category as the cash flows from the hedged item in the Consolidated Statements of Cash Flows. The Company may also enter into certain foreign currency and interest rate instruments that economically hedge certain of its risks but do not qualify for hedge accounting. Changes in fair value of these derivative instruments, based on quoted market prices, are recognized in earnings each period. The Company’s derivative instruments and other financial instruments are more fully described in Note 7, along with the related fair value measurement considerations. Stock-Based Compensation The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock, based on the fair value of those awards at the date of grant over the requisite service period. The Company uses the Black-Scholes-Merton (Black-Scholes) option pricing model to determine the fair value of stock option awards. Stock-based compensation plans, related expenses and assumptions used in the Black-Scholes option pricing model are more fully described in Note 8. Currency Translation The assets and liabilities of foreign subsidiaries, other than those operating in highly inflationary environments, are translated into U.S. dollars at year-end exchange rates with resulting translation gains and losses accumulated in a separate component of shareholders’ equity. Income and expense items are translated into U.S. dollars at average rates of exchange prevailing during the year. For subsidiaries operating in highly inflationary environments (currently, Venezuela), non-monetary assets, such as inventories, prepaid expenses, goodwill and property, plant and equipment are remeasured at their historical exchange rates, while monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these operations are included in Net income attributable to Colgate-Palmolive Company. Recent Accounting Pronouncements In February 2013, the FASB issued ASU No. 2013-02, "Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income." ASU No. 2013-02 requires presentation of reclassification adjustments from each component of accumulated other comprehensive income either in a single note or parenthetically on the face of the financial statements, for those amounts required to be reclassified into Net income in their entirety in the same reporting period. For amounts that are not required to be reclassified in their entirety in the same reporting period, cross-reference to other disclosures is required. As permitted under ASU 2013-02, the Company has elected to present reclassification adjustments from each component of accumulated other comprehensive income within a single note to the financial statements beginning the in first quarter of 2013. In June 2011, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2011-05, “Presentation of Comprehensive Income.” ASU No. 2011-05 eliminates the current option to disclose other comprehensive income and its components in the statement of changes in equity. As permitted under ASU No. 2011-05, the Company has elected to present items of Net income and Other comprehensive income in two separate consecutive statements beginning in the first quarter of 2012. Reclassifications Certain prior year amounts have been reclassified to conform to the current year presentation.

Acquisitions and Divestitures

12 Months Ended

Dec. 31, 2012

Acquisitions And Divestitures

Acquisitions and Divestitures

Sanex Acquisition

On June 20, 2011, the Company, Colgate-Palmolive Europe Sàrl, Unilever N.V. and Unilever PLC (together with Unilever N.V., “Unilever”) finalized the Company’s acquisition from Unilever of the Sanex personal care business in accordance with a Business and Share Sale and Purchase Agreement (the “Purchase Agreement”) for an aggregate purchase price of €676 ($966). The acquisition was financed with available cash, proceeds from the sale of the Company’s Euro-denominated investment portfolio and the issuance of commercial paper.

Total purchase price consideration of $966 was allocated to the net assets acquired based on their respective fair values at June 20, 2011, as follows:



Recognized amounts of assets acquired and liabilities assumed:
Inventories	$	26
Property, plant and equipment, net	3
Other intangible assets, net	596
Goodwill, net	411
Accrued income taxes	(48		)
Long-term deferred income taxes	(18		)
Long-term other liabilities	(4		)
Fair value of net assets acquired	$	966

Other intangible assets acquired include trademarks of $403 with an indefinite useful life and customer relationships of $193 with useful lives ranging from 15 to 18 years.

Goodwill of $411 was allocated between the Europe/South Pacific segment (90%) and the Greater Asia/Africa segment (10%). The Company expects that substantially all of the goodwill will be deductible for tax purposes.

Pro forma results of operations have not been presented, as the impact on the Company’s consolidated financial statements is not material. In 2011, Other (income) expense, net includes $12 in transaction costs related to the acquisition.

Sale of Detergent Business in Colombia

In connection with the Sanex acquisition, Colgate sold its non-core laundry detergent business in Colombia to Unilever for $215. The detergent sale closed on July 29, 2011 and, as a result of the sale, the Company recognized a pretax gain of $207 ($135 aftertax gain) included in Other (income) expense, net in the third quarter of 2011. These operations were not material to the Company’s annual Net sales, Net income or Earnings per share.

Sale of Land in Mexico

On September 13, 2011, the Company’s Mexican subsidiary entered into an agreement to sell to the United States of America the Mexico City site on which its commercial operations, technology center and soap production facility are located. The sale price is payable in three installments, with the final installment due upon the transfer of the property, which is expected to occur in 2014. During the third quarter of 2011, the Company received the first installment of $24 upon signing the agreement. During the third quarter of 2012, the Company received the second installment of $36. The Company is re-investing these payments to relocate its soap production to a new state-of-the-art facility to be constructed at its Mission Hills, Mexico site, to relocate its commercial and technology operations within Mexico City and to prepare the existing site for transfer. As a result, the Company expects to make capital improvements and incur costs to exit the site through 2014. These exit costs will primarily be related to staff leaving indemnities, accelerated depreciation and demolition to make the site building-ready. In 2012 and 2011, the Company recorded $24 and $13 of pretax costs ($18 and $9 of aftertax costs), respectively, related to the sale.

Sale of Non-core Product Lines in Latin America

During the fourth quarter of 2010, consistent with the Company’s strategy to prioritize its higher-margin businesses, the Company sold certain non-core product lines in Latin America, resulting in a pretax gain of $50 ($30 aftertax gain) included in Other (income) expense, net. These operations were not material to the Company’s annual Net sales, Net income or Earnings per share.

Restructuring and Related Implementation Charges

12 Months Ended

Dec. 31, 2012

Restructuring and Related Activities [Abstract]

Restructuring and Related Implementation Charges

In the fourth quarter of 2012, the Company commenced a four-year Global Growth and Efficiency Program (the 2012 Restructuring Program) for sustained growth. The program’s initiatives are expected to help Colgate ensure continued solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses.

Implementation of the 2012 Restructuring Program is projected to result in cumulative pretax charges, once all phases are approved and implemented, totaling between $1,100 and $1,250 ($775 and $875 aftertax), which are currently estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (50%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (15%); and Other charges, which include contract termination costs, consisting primarily of implementation-related charges resulting directly from exit activities (20%) and the implementation of new strategies (15%). The anticipated pretax charges for 2013 are expected to amount to approximately $260 to $310 ($185 to $220 aftertax). Over the course of the four-year 2012 Restructuring Program, it is estimated that approximately 75% of the charges will result in cash expenditures.

It is expected that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe/South Pacific (20%), Latin America (5%), Greater Asia/Africa (10%), Hill’s Pet Nutrition (15%) and Corporate (35%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. It is expected that by the end of 2016, the 2012 Restructuring Program will reduce the Company’s global employee workforce by approximately 6% from the 2012 level of approximately 38,000.

For the year ended December 31, 2012 restructuring and implementation-related charges are reflected in the income statement as follows:



	2012
Cost of sales	$	2
Selling, general and administrative expenses	6
Other (income) expense, net	81
Total 2012 Restructuring Program charges, pretax	$	89

Total 2012 Restructuring Program charges, aftertax	$	70

Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance. Total 2012 charges relate to restructuring and implementation activity in North America (2%), Europe/South Pacific (55%), Greater Asia/Africa (2%), Hill’s Pet Nutrition (3%) and Corporate (38%).

Costs incurred during the fourth quarter of 2012 primarily concern projects related to the simplification and streamlining of the Company's research and development capabilities and oral care supply chain in Europe as well as the restructuring of certain commercial operations in advance of implementing an overall hubbing strategy.

The following table summarizes the activity for the restructuring and implementation-related charges discussed above and the related accrual:



	Employee-Related Costs			Incremental Depreciation		Asset Impairments		Other			Total
Charges	$	78		$	—	$	—	$	11		$	89
Cash payments	(1		)	—		—		(4		)	(5		)
Charges against assets	—			—		—		—			—
Other	—			—		—		—			—
Foreign exchange	7			—		—		(2		)	5
Balance at December 31, 2012	$	84		$	—	$	—	$	5		$	89

Employee-related costs primarily included severance and other termination benefits and were calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements.

Other charges consisted primarily of implementation-related charges resulting directly from exit activities and the implementation of new strategies as a result of the 2012 Restructuring Program. These charges included third-party incremental costs of $8 related to the development and implementation of new business and strategic initiatives and contract termination costs of $3 directly related to the 2012 Restructuring Program. These charges were expensed as incurred.

The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.

Goodwill and Other Intangible Assets

12 Months Ended

Dec. 31, 2012

Goodwill and Other Intangible Assets

The net carrying value of Goodwill as of December 31, 2012 and 2011, by segment is as follows:



	2012		2011
Oral, Personal and Home Care
North America	$	374	$	370
Latin America	406		434
Europe/South Pacific	1,478		1,450
Greater Asia/Africa	227		225
Total Oral, Personal and Home Care	2,485		2,479
Pet Nutrition	15		15
Total Goodwill, net	$	2,500	$	2,494

The change in the amount of Goodwill, net during 2012 is primarily due to the impact of foreign currency translation. The change in the amount of Goodwill, net during 2011 is primarily due to the acquisition of Sanex (see Note 3) and the impact of foreign currency translation.

Other intangible assets as of December 31, 2012 and 2011 are comprised of the following:



	2012							2011
	Gross Carrying Amount		Accumulated Amortization			Net		Gross Carrying Amount		Accumulated Amortization			Net
Trademarks	$	548	$	(254	)	$	294	$	536	$	(236	)	$	300
Other finite life intangible assets	212		(34		)	178		205		(18		)	187
Indefinite life intangible assets	1,027		—			1,027		1,017		—			1,017
Total Other intangible assets	$	1,787	$	(288	)	$	1,499	$	1,758	$	(254	)	$	1,504

The changes in the net carrying amounts of Other intangible assets during 2012, 2011 and 2010 were partially due to amortization expense of $31, $28 and $22, respectively, as well as the impact of foreign currency translation. In addition, in 2012 and 2011, Indefinite life intangible assets included trademarks of $403 and Other finite life intangible assets included customer relationships of $193 acquired in connection with the Sanex acquisition (see Note 3). Annual estimated amortization expense for each of the next five years is expected to be approximately $29.

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

Long-Term Debt and Credit Facilities

12 Months Ended

Dec. 31, 2012

Long-Term Debt and Credit Facilities

Long-term debt consists of the following at December 31:



	Weighted Average Interest Rate		Maturities			2012		2011
Notes	2.1	%	2013	-	2078	$	4,733	$	4,089
Payable to banks	—	%	2013			—		16
Commercial paper	0.1	%	2013			443		671
						5,176		4,776
Less: Current portion of long-term debt						250		346
Total						$	4,926	$	4,430

The weighted-average interest rate on short-term borrowings of $54 in 2012 and $34 in 2011 included in Notes and loans payable in the Consolidated Balance Sheets as of December 31, 2012 and 2011 was 1.0% and 0.9%, respectively.

Commercial paper is classified as long-term debt as the Company has the intent and ability to refinance such obligations on a long-term basis. Excluding commercial paper reclassified as long-term debt, scheduled maturities of long-term debt and capitalized leases outstanding as of December 31, 2012, are as follows:



Years Ended December 31,
2013	$	250
2014	887
2015	494
2016	254
2017	678
Thereafter	2,170

The Company has entered into interest rate swap agreements and foreign exchange contracts related to certain of these debt instruments. See Note 7 for further information about the Company’s financial instruments.

During the third quarter of 2012, the Company issued $500 of U.S. dollar-denominated ten-year notes at a fixed rate of 1.95% under the Company’s shelf registration statement. During the second quarter of 2012, the Company issued $500 of U.S. dollar-denominated ten-year notes at a fixed rate of 2.3% under the Company’s shelf registration statement. Proceeds from the debt issuances were used to reduce commercial paper borrowings.

During the fourth quarter of 2011, the Company issued $300 of U.S. dollar-denominated three-year notes at a fixed rate of 0.6%, $400 of U.S. dollar-denominated five-year notes at a fixed rate of 1.3% and $300 of U.S. dollar-denominated ten-year notes at a fixed rate of 2.45% under the Company’s shelf registration statement. During the second quarter of 2011, the Company issued $250 of U.S. dollar-denominated three-year notes at a fixed rate of 1.25% and $250 of U.S. dollar-denominated six-year notes at a fixed rate of 2.625% under the Company’s shelf registration statement. Proceeds from the debt issuances in 2011 were used to reduce commercial paper borrowings and to repay outstanding indebtedness under a credit facility.

At December 31, 2012, the Company had access to unused domestic and foreign lines of credit of $2,547 (including under the two facilities discussed below) and could also issue medium-term notes pursuant to an effective shelf registration statement. In November 2011, the Company entered into a new five-year revolving credit facility with a capacity of $1,850 with a syndicate of banks. In 2012, this facility was extended for an additional year and will expire in November 2017. The Company also has the ability to draw $145 from a revolving credit facility that expires in November 2013. Commitment fees related to credit facilities are not material.

Certain agreements with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote.

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

Financial Instruments and Fair Value Measurements [Abstract]

Fair Value Measurements and Financial Instruments

12 Months Ended

Dec. 31, 2012

Financial Instruments and Fair Value Measurements

Fair Value Measurements and Financial Instruments

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Hedge ineffectiveness, if any, is not material for any period presented. Provided below are details of the Company’s exposures by type of risk and derivative instruments by type of hedge designation.

Valuation Considerations

Assets and liabilities carried at fair value are classified as follows:

Level 1: Based upon quoted market prices in active markets for identical assets or liabilities.

Level 2: Based upon observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: Based upon unobservable inputs reflecting the reporting entity’s own assumptions.

Foreign Exchange Risk

As the Company markets its products in over 200 countries and territories, it is exposed to currency fluctuations related to manufacturing and selling its products in currencies other than the U.S. dollar. The Company manages its foreign currency exposures through a combination of cost-containment measures, selling price increases and the hedging of certain costs in an effort to minimize the impact on earnings of foreign currency rate movements.

The Company primarily utilizes foreign currency contracts, including forward, option and swap contracts, local currency deposits and local currency borrowings to hedge portions of its exposures relating to foreign currency purchases, assets and liabilities created in the normal course of business and the net investment in certain foreign subsidiaries. The duration of foreign currency contracts generally does not exceed 12 months and the contracts are valued using observable market rates (Level 2 valuation).

Interest Rate Risk

The Company manages its targeted mix of fixed and floating rate debt with debt issuances and by entering into interest rate swaps in order to mitigate fluctuations in earnings and cash flows that may result from interest rate volatility. The notional amount, interest payment and maturity date of the swaps match the principal, interest payment and maturity date of the related debt in all cases, and the swaps are valued using observable benchmark rates (Level 2 valuation).

Commodity Price Risk

The Company is exposed to price volatility related to raw materials used in production, such as resins, tropical oils, essential oils, tallow, poultry, corn and soybeans. The Company manages its raw material exposures through a combination of cost containment measures, ongoing productivity initiatives and the limited use of commodity hedging contracts. Futures contracts are used on a limited basis, primarily in the Pet Nutrition segment, to manage volatility related to raw material inventory purchases of certain traded commodities, and these contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of the commodity contracts generally does not exceed 12 months.

Credit Risk

The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material as it is the Company’s policy to contract with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at December 31, 2012 and December 31, 2011:



	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		12/31/12		12/31/11			12/31/12		12/31/11
Interest rate swap contracts	Other current assets	$	3	$	2	Other accruals	$	—	$	—
Interest rate swap contracts	Other assets	41		40		Other liabilities	—		2
Foreign currency contracts	Other current assets	7		8		Other accruals	10		6
Foreign currency contracts	Other assets	13		28		Other liabilities	—		—
Commodity contracts	Other current assets	1		—		Other accruals	—		1
Total designated		$	65	$	78		$	10	$	9

Derivatives not designated
Foreign currency contracts	Other assets	$	—	$	3	Other liabilities	$	1	$	—
Total not designated		$	—	$	3		$	1	$	—

Total derivative instruments		$	65	$	81		$	11	$	9

Other financial instruments
Marketable securities	Other current assets	$	116	$	72
Venezuelan bonds, long-term	Other assets	618		236
Total other financial instruments		$	734	$	308

The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of December 31, 2012 and 2011. The estimated fair value of the Company’s long-term debt, including the current portion, as of December 31, 2012 and 2011, was $5,484 and $5,121, respectively, and the related carrying value was $5,176 and $4,776, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

Fair value hedges

The Company has designated all interest rate swap contracts and certain foreign currency forward and option contracts as fair value hedges, for which the gain or loss on the derivative and the offsetting loss or gain on the hedged item are recognized in current earnings. The impact of foreign currency contracts is primarily recognized in Selling, general and administrative expenses and the impact of interest rate swap contracts is recognized in Interest expense, net. Activity related to fair value hedges recorded during each period presented was as follows:



	2012									2011
	Foreign Currency Contracts			Interest Rate Swaps			Total			Foreign Currency Contracts			Interest Rate Swaps			Total
Notional Value at December 31,	$	1,117		$	1,338		$	2,455		$	670		$	1,668		$	2,338
Gain (loss) on derivative	9			6			15			5			25			30
Gain (loss) on hedged items	(9		)	(6		)	(15		)	(5		)	(25		)	(30		)

Cash flow hedges

All of the Company’s commodity contracts and certain foreign currency forward contracts have been designated as cash flow hedges, for which the effective portion of the gain or loss is reported as a component of Other comprehensive income (OCI) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Activity related to cash flow hedges recorded during each period presented was as follows:



	2012						2011
	Foreign Currency Contracts		Commodity Contracts		Total		Foreign Currency Contracts			Commodity Contracts			Total
Notional Value at December 31,	$	398	$	23	$	421	$	403		$	32		$	435
Gain (loss) recognized in OCI	4		9		13		(9		)	(1		)	(10		)
Gain (loss) reclassified into Cost of sales	4		7		11		(13		)	4			(9		)

The net gain (loss) recognized in OCI for both foreign currency contracts and commodity contracts is expected to be recognized in Cost of sales within the next twelve months.

Net investment hedges

The Company has designated certain foreign currency forward and option contracts and certain foreign currency-denominated debt as net investment hedges, for which the gain or loss on the instrument is reported as a component of Currency translation adjustments within OCI, along with the offsetting gain or loss on the hedged items. Activity related to net investment hedges recorded during each period presented was as follows:



	2012									2011
	Foreign Currency Contracts			Foreign Currency Debt			Total			Foreign Currency Contracts			Foreign Currency Debt			Total
Notional Value at December 31,	$	522		$	383		$	905		$	485		$	194		$	679
Gain (loss) on instruments	(11		)	(8		)	(19		)	8			1			9
Gain (loss) on hedged items	8			8			16			(8		)	(1		)	(9		)

Derivatives Not Designated as Hedging Instruments

Derivatives not designated as hedging instruments for each period consist of a cross-currency swap that serves as an economic hedge of a foreign currency deposit, for which the gain or loss on the instrument and the offsetting gain or loss on the hedged item are recognized in Other (income) expense, net for each period. The cross-currency swap outstanding at December 31, 2010 was settled during the second quarter of 2011, resulting in a realized loss of $6 which was offset by a corresponding gain on an underlying deposit. A new cross-currency swap with similar terms and an underlying foreign currency deposit was entered into during June 2011. Activity related to these contracts during each period presented was as follows:



	2012			2011
	Cross-currency Swap			Cross-currency Swap
Notional Value at December 31,	$	96		$	96
Gain (loss) on instrument	(4		)	(1		)
Gain (loss) on hedged item	4			1

Other Financial Instruments

Other financial instruments are classified as Other current assets or Other assets.

Other financial instruments classified as Other current assets include marketable securities, which consist of bank deposits of $92 with original maturities greater than 90 days (Level 1 valuation) and the current portion of bonds issued by the Venezuelan government (Level 2 valuation) in the amount of $24. The long-term portion of these bonds in the amount of $618 is included in Other assets.

Through its subsidiary in Venezuela, the Company is invested in both U.S. dollar-linked, devaluation-protected bonds and bolivar fuerte denominated fixed interest rate bonds, issued by the Venezuelan government. These bonds are actively traded and, therefore, are considered Level 2 investments as their values are determined based upon observable market-based inputs or unobservable inputs that are corroborated by market data. As of December 31, 2012, the fair market value of U.S. dollar-linked, devaluation-protected bonds and bolivar fuerte fixed interest rate bonds were $255 and $387, respectively. These bonds are accounted for as available-for-sale securities.

The following table presents a reconciliation of the Venezuelan bonds at fair value for the twelve months ended December 31:



	2012		2011
Beginning balance as of January 1	$	236	$	96
Unrealized gain (loss) on investment	28		61
Purchases and sales during the period	378		79
Ending balance as of December 31	$	642	$	236

As a result of the Venezuelan government’s elimination of the two-tier exchange rate structure effective January 1, 2011, the U.S. dollar-linked, devaluation-protected bonds were revalued and the Company recorded an unrealized gain of $62 in the first quarter of 2011. For further information regarding Venezuela, refer to Note 14.

Capital Stock and Stock-Based Compensation Plans

12 Months Ended

Dec. 31, 2012

Capital Stock and Stock-Based Compensation Plans

Preference Stock

The Company has the authority to issue 50,000,000 shares of Preference stock. In 1989, the Company approved the issuance of 6,315,149 shares of Series B Convertible Preference stock (the Preference stock) without par value. Each share of Preference stock, which was convertible into eight shares of common stock, had a redemption price of $65 per share and paid cumulative dividends equal to the higher of $2.44 or the current dividend paid on eight common shares for the comparable six-month period. As a result of rules issued by the IRS related to employer stock held in defined contribution plans, the Company issued a notice of redemption with respect to the 2,405,192 shares of Preference stock outstanding on December 29, 2010. At the direction of the Company’s Employee Stock Ownership Plan trustee, the shares of Preference stock were converted into 19,241,536 shares of common stock. The common stock for the conversion was issued from treasury shares. See Note 9 for further information about the Company’s Employee Stock Ownership Plan.

Stock Repurchases

The Company repurchased its common stock at a cost of $1,943 during 2012 under a share repurchase program that was approved by the Board of Directors and publicly announced in September 2011 (the 2011 Program). The 2011 Program authorized the Company to repurchase up to 50 million shares of its common stock. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares may be repurchased in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.

The Company may use either authorized and unissued shares or treasury shares to meet share requirements resulting from the exercise of stock options and the vesting of restricted stock awards.

A summary of common stock and treasury stock activity for the three years ended December 31, is as follows:



	Common Stock Outstanding		Treasury Stock
Balance, January 1, 2010	494,165,017		238,688,163

Common stock acquired	(25,401,785	)	25,401,785
Shares issued for stock options	4,233,775		(4,233,775	)
Shares issued for restricted stock and other	993,132		(993,132	)
Preference stock conversion	20,860,328		(20,860,328	)
Balance, December 31, 2010	494,850,467		238,002,713

Common stock acquired	(21,320,936	)	21,320,936
Shares issued for stock options	5,758,879		(5,758,879	)
Shares issued for restricted stock and other	729,665		(729,665	)
Balance, December 31, 2011	480,018,075		252,835,105

Common stock acquired	(19,365,301	)	19,365,301
Shares issued for stock options	6,108,615		(6,108,615	)
Shares issued for restricted stock and other	1,102,949		(1,102,949	)
Balance, December 31, 2012	467,864,338		264,988,842

Stock-Based Compensation

The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock, based on the fair value of those awards at the date of grant. The value of restricted stock awards, based on market prices, is amortized on a straight-line basis over the requisite service period. The estimated fair value of stock options on the date of grant is amortized on a straight-line basis over the requisite service period for each separately vesting portion of the award. Awards to employees eligible for retirement prior to the award becoming fully vested are recognized as compensation cost over the period through the date that the employee first becomes eligible to retire and is no longer required to provide service to earn the award.

The Company has two types of stock-based compensation plans, which are described below. The total stock-based compensation expense charged against pretax income for these plans was $120, $122 and $121 for the years ended December 31, 2012, 2011 and 2010, respectively. The total income tax benefit recognized on stock-based compensation was approximately $37 for the year ended December 31, 2012 and approximately $40 for each of the years ended December 31, 2011 and 2010.

Stock-based compensation expense is recorded within Selling, general and administrative expenses in the Corporate segment as these amounts are not included in internal measures of segment operating performance.

The Company uses the Black-Scholes option pricing model to determine the fair value of stock-option awards. The weighted-average estimated fair value of stock options granted in the years ended December 31, 2012, 2011 and 2010 was $13.46, $11.93 and $11.00, respectively. Fair value is estimated using the Black-Scholes option pricing model with the assumptions summarized in the following table:



	2012		2011		2010
Expected Term of Options	4.5 years		4.5 years		4.5 years
Expected Volatility Rate	20.8	%	21.3	%	22.5	%
Risk-Free Rate	0.6	%	0.8	%	1.3	%
Expected Dividend Yield	2.4	%	2.6	%	2.8	%

The weighted-average expected term of options granted each year was determined with reference to historical exercise and post-vesting cancellation experience, the vesting period of the awards and contractual term of the awards, among other factors. Expected volatility incorporates implied share-price volatility derived from exchange traded options on the Company’s common stock. The risk-free rate for the expected term of the option is based on the U.S. Treasury implied yield at the time of grant.

Incentive Stock Plan

The Company has a plan that provides for grants of restricted stock awards for officers and other employees. The Personnel and Organization Committee of the Board of Directors, comprised entirely of independent directors, administers the plan. Awards are made in restricted stock units and vest at the end of the restriction period, which is generally three years. As of December 31, 2012, 8,650,000 shares of common stock were available for future restricted stock awards.

A summary of restricted stock award activity during 2012 is presented below:



	Shares (in thousands)		Weighted Average Grant Date Fair Value Per Award
Restricted stock awards as of January 1, 2012	3,037		$	76
Activity:
Granted	734		100
Vested	(1,062	)	66
Forfeited	(75	)	82
Restricted stock awards as of December 31, 2012	2,634		$	87

As of December 31, 2012, there was $70 of total unrecognized compensation expense related to nonvested restricted stock awards, which will be recognized over a weighted-average period of 2.3 years. The total fair value of shares vested during the years ended December 31, 2012, 2011 and 2010 was $63, $50 and $69, respectively.

Stock Option Plans

The Company’s stock option plans provide for the issuance to directors, officers and other employees of non-qualified stock options that generally have a contractual term of six years and vest over three years. As of December 31, 2012, 3,999,000 shares of common stock were available for future stock option grants.

A summary of stock option plan activity during 2012 is presented below:



	Shares (in thousands)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)	Value of Unexercised In-the-Money Options
Options outstanding, January 1, 2012	22,294		$	76
Granted	5,261		104
Exercised	(6,217	)	68
Forfeited or expired	(167	)	85
Options outstanding, December 31, 2012	21,171		85		4	$	406
Options exercisable, December 31, 2012	11,635		$	77	3	$	322

As of December 31, 2012, there was $48 of total unrecognized compensation expense related to options, which will be recognized over a weighted-average period of 1.6 years. The total intrinsic value of options exercised during the years ended December 31, 2012, 2011 and 2010 was $210, $162 and $133, respectively.

The benefits of tax deductions in excess of grant date fair value resulting from the exercise of stock options and vesting of restricted stock awards for the years ended December 31, 2012, 2011 and 2010 was $60, $32 and $31, respectively, and was reported as a financing cash flow. Cash proceeds received from options exercised for the years ended December 31, 2012, 2011 and 2010 were $409, $332 and $211, respectively.

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 40
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 14

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 123R
-Paragraph 64, 65, A240
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Statement of Position (SOP)
-Number 93-6
-Paragraph 53
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Employee Stock Ownership Plan	12 Months Ended
Employee Stock Ownership Plan	Dec. 31, 2012
Notes to Financial Statements [Abstract]
Employee Stock Ownership Plan	Employee Stock Ownership Plan In 1989, the Company expanded its Employee Stock Ownership Plan (ESOP) through the introduction of a leveraged ESOP that funds certain benefits for employees who have met eligibility requirements. The ESOP issued $410 of long-term notes due through July 2009 bearing an average interest rate of 8.7%. The notes, which were guaranteed by the Company, were repaid in July 2009. The ESOP used the proceeds from the notes issuance to purchase 6,315,149 shares of Preference stock from the Company. The Preference stock, each share of which was convertible into eight shares of common stock, had a redemption price of $65 per share and paid semiannual dividends equal to the higher of $2.44 or the current dividend paid on eight common shares for the comparable six-month period. As a result of rules issued by the IRS related to employer stock held in defined contribution plans, the Company issued a notice of redemption with respect to the 2,405,192 shares of Preference stock outstanding on December 29, 2010. At the direction of the Company’s ESOP trustee, the shares of Preference stock were converted into 19,241,536 shares of common stock. As of December 31, 2012 and 2011, there were 15,610,648 and 17,102,005 shares of common stock, respectively, outstanding and issued to the Company's ESOP. The common stock for the conversion was issued from treasury shares. See Note 8. During 2000, the ESOP entered into a loan agreement with the Company under which the benefits of the ESOP may be extended through 2035. Advances from the Company of $41 remain outstanding at December 31, 2012. Dividends on stock held by the ESOP are paid to the ESOP trust and, together with cash contributions and advances from the Company, are (a) used by the ESOP to repay principal and interest, (b) credited to participant accounts or (c) used for Plan contributions. Stock is allocated to participants based upon the ratio of the current year’s debt service to the sum of total principal and interest payments over the life of the debt. As of December 31, 2012, 9,635,421 common shares were released and allocated to participant accounts and 5,975,227 common shares were available for future allocation to participant accounts. Dividends on the stock used to repay principal and interest or credited to participant accounts and eligible for cash payment upon crediting are deductible for income tax purposes and, accordingly, are reflected net of their tax benefit in the Consolidated Statements of Changes in Shareholders’ Equity. Annual expense related to the leveraged ESOP, determined as interest incurred on the original notes, plus the higher of either principal payments or the historical cost of Common shares allocated, less dividends received on the shares held by the ESOP and advances from the Company, was $0 in 2012 and 2011 and $6 in 2010. Unearned compensation, which is shown as a reduction in Shareholders’ equity, is the amount of ESOP debt due to the Company. Interest incurred on the ESOP notes was $0 in 2012, 2011, and 2010. The Company paid dividends on the shares held by the ESOP of $40 in 2012, $42 in 2011 and $41 in 2010. Company contributions to the ESOP were $0 in 2012 and 2011 and $6 in 2010.

Tabular disclosure of the description of the plan, the basis for determining contributions, including the employee groups covered, and the nature and effect of significant matters affecting comparability of information for all periods presented. For leveraged ESOPs and pension reversion ESOPs, the disclosure may include the basis for releasing shares and how dividends on allocated and unallocated shares are used. Disclosure may also include a description of the accounting policies followed for ESOP transactions, including the method of measuring compensation, the classification of dividends on ESOP shares, and the treatment of ESOP shares for EPS computations. If the employer has both old ESOP shares for which it does not adopt the latest guidance and new ESOP shares for which the new guidance is required, the accounting policies for both blocks of shares may be described. Disclosure may also include he amount of compensation cost recognized during the period, the number of allocated shares, committed-to-be-released shares, and suspense shares held by the ESOP at the balance-sheet date, the fair value of unearned ESOP shares at the balance-sheet date for shares accounted for under the latest guidance, the existence and nature of any repurchase obligation, including disclosure of the fair value of the shares allocated as of the balance sheet date, which are subject to a repurchase obligation.

Retirement Plans and Other Retiree Benefits

12 Months Ended

Dec. 31, 2012

Retirement Plans and Other Retiree Benefits

Retirement Plans

The Company and certain of its U.S. and overseas subsidiaries maintain defined benefit retirement plans. Benefits under these plans are based primarily on years of service and employees’ career earnings.

Effective September 1, 2010, the Company adopted certain amendments to its retirement benefit programs in the U.S. The plan amendments provide for higher contributions to the Company’s defined contribution plan while reducing future pay credits to the Company’s defined benefit plan for participants, simplification of the formula for calculating monthly pay-based credits to the defined benefit plan and certain pension enhancements depending on years of service.

In the Company’s principal U.S. plans and certain funded overseas plans, funds are contributed to trusts in accordance with regulatory limits to provide for current service and for any unfunded projected benefit obligation over a reasonable period. The target asset allocation for the Company’s defined benefit plans are as follows:



	United States		International
Asset Category
Equity securities	52	%	43	%
Debt securities	40		42
Real estate and alternative investments	8		15
Total	100	%	100	%

At December 31, 2012 the allocation of the Company’s plan assets and the level of valuation input for each major asset category was as follows:



	Level of Valuation Input	Pension Plans
	Level of Valuation Input	United States		International		Other Retiree Benefits
Investments:
Cash & cash equivalents	Level 1	$	45	$	9	$	1
U.S. common stocks	Level 1	258		—		6
International common stocks	Level 1	93		—		2
Fixed income securities (a)	Level 2	142		—		—
Common/collective trust funds (b):	Level 2
Equity index funds		444		199		11
Emerging market equity index funds		65		12		2
Other common stock funds		40		65		1
Fixed income funds: U.S. or foreign government and agency securities		227		59		6
Fixed income funds: investment grade corporate bonds		26		72		1
Fixed income funds: high yield corporate bonds and other		185		1		5
Guaranteed investment contracts (c)	Level 2	2		49		—
Real estate (d)	Level 3	70		20		2
Total Investments at fair value		$	1,597	$	486	$	37

At December 31, 2011 the allocation of the Company’s plan assets and the level of valuation input for each major asset category was as follows:



	Level of Valuation Input	Pension Plans
	Level of Valuation Input	United States		International		Other Retiree Benefits
Investments:
Cash & cash equivalents	Level 1	$	67	$	12	$	2
U.S. common stocks	Level 1	209		—		5
International common stocks	Level 1	47		—		1
Fixed income securities (a)	Level 2	145		—		—
Common/collective trust funds (b):	Level 2
Equity index funds		405		158		10
Emerging market equity index funds		54		17		1
Other common stock funds		34		28		1
Fixed income funds: U.S. or foreign government and agency securities		268		82		7
Fixed income funds: investment grade corporate bonds		58		75		1
Fixed income funds: high yield corporate bonds and other		75		1		2
Guaranteed investment contracts (c)	Level 2	2		46		—
Real estate (d)	Level 3	62		18		2
Total Investments at fair value		$	1,426	$	437	$	32

_______


(a)	The fixed income securities are traded over the counter and a small portion of the securities lack daily pricing or liquidity and as such are classified as Level 2. As of December 31, 2012 and 2011, approximately 75% of the fixed income portfolio was invested in U.S. treasury or agency securities, with the remainder invested in corporate bonds.


(b)	Interests in common/collective trust funds are valued using the net asset value (NAV) per unit in each fund. The NAV is based on the value of the underlying investments owned by each trust, minus its liabilities, divided by the number of shares outstanding.


(c)	The guaranteed investment contracts (GICs) represent contracts with insurance companies measured at the cash surrender value of each contract. The Level 2 valuation reflects that the cash surrender value is based principally on a referenced pool of investment funds with active redemption.


(d)	Real estate is valued using the NAV per unit of funds that are invested in real property, and the real property is valued using independent market appraisals. Since the appraisals include unobservable inputs, the investments in each fund are classified as Level 3.

The following table presents a reconciliation of Level 3 plan assets measured at fair value for the year ended December 31:



	2012				2011
	United States Real Estate Fund		International Real Estate Fund		United States Real Estate Fund			International Real Estate Fund
Beginning balance as of January 1	$	64	$	18	$	55		$	16
Earned income, net of management expenses	6		—		9			—
Unrealized gain on investment	2		1		2			1
Purchases, sales, issuances and settlements, net	—		1		(2		)	1
Ending balance as of December 31	$	72	$	20	$	64		$	18

Equity securities in the U.S. plans include investments in the Company’s common stock representing 11% of U.S. plan assets at both December 31, 2012 and 2011. No shares of the Company’s common stock were purchased or sold by the plans in 2012 or 2011. The plans received dividends on the Company’s common stock of $4 in 2012 and $3 in 2011.

Other Retiree Benefits

The Company and certain of its subsidiaries provide health care and life insurance benefits for retired employees to the extent not provided by government-sponsored plans. The Company utilizes a portion of its leveraged ESOP to reduce its obligation to provide these other retiree benefits and to offset its current service cost.

Effective September 1, 2010, the Company adopted certain amendments to its retirement benefit programs in the U.S. Effective with the plan amendments, future retirees of the Company who do not meet certain age and service requirements will begin to share in the cost of retiree medical coverage through monthly payments rather than paying a lump sum contribution at retirement. In addition, the Company will generally no longer use its leveraged ESOP to make retiree medical coverage allocations. The incremental impact to the Company’s net income due to the plan amendments for 2010 was not significant.

The Company uses a December 31 measurement date for its defined benefit and other retiree benefit plans. Summarized information for the Company’s defined benefit and other retiree benefit plans are as follows:



	Pension Benefits												Other Retiree Benefits
	2012			2011			2012			2011			2012			2011
	United States						International
Change in Benefit Obligations
Benefit obligations at beginning of year	$	2,025		$	1,952		$	760		$	736		$	776		$	762
Service cost	24			24			12			19			9			10
Interest cost	97			100			35			36			40			39
Participants’ contributions	1			1			3			4			—			—
Acquisitions/plan amendments	—			—			21			1			(27		)	—
Actuarial loss (gain)	200			126			103			21			119			(1		)
Foreign exchange impact	—			—			21			(10		)	1			(6		)
Termination benefits	—			—			—			—			—			—
Curtailments and settlements	—			—			(23		)	(14		)	—			1
Benefit payments	(128		)	(178		)	(45		)	(33		)	(40		)	(29		)
Other	8			—			1			—			(3		)	—
Benefit obligations at end of year	$	2,227		$	2,025		$	888		$	760		$	875		$	776
Change in Plan Assets
Fair value of plan assets at beginning of year	$	1,426		$	1,377		$	437		$	434		$	32		$	32
Actual return on plan assets	173			28			47			2			5			—
Company contributions	125			198			57			45			40			29
Participants’ contributions	1			1			3			4			—			—
Foreign exchange impact	—			—			13			(3		)	—			—
Settlements	—			—			(21		)	(12		)	—			—
Benefit payments	(128		)	(178		)	(45		)	(33		)	(40		)	(29		)
Other	—			—			(5		)	—			—			—
Fair value of plan assets at end of year	$	1,597		$	1,426		$	486		$	437		$	37		$	32
Funded Status
Benefit obligations at end of year	$	2,227		$	2,025		$	888		$	760		$	875		$	776
Fair value of plan assets at end of year	1,597			1,426			486			437			37			32
Net amount recognized	$	(630	)	$	(599	)	$	(402	)	$	(323	)	$	(838	)	$	(744	)
Amounts Recognized in Balance Sheet
Noncurrent assets	$	—		$	—		$	2		$	—		$	—		$	—
Current liabilities	(17		)	(15		)	(29		)	(29		)	(40		)	(40		)
Noncurrent liabilities	(613		)	(584		)	(375		)	(294		)	(798		)	(704		)
Net amount recognized	$	(630	)	$	(599	)	$	(402	)	$	(323	)	$	(838	)	$	(744	)
Amounts recognized in Accumulated other comprehensive income consist of
Actuarial loss	$	932		$	855		$	235		$	174		$	421		$	323
Transition/prior service cost	63			73			26			6			2			32
	$	995		$	928		$	261		$	180		$	423		$	355
Accumulated benefit obligation	$	2,093		$	1,892		$	798		$	688		$	—		$	—



	Pension Benefits						Other Retiree Benefits
	2012		2011	2012		2011	2012		2011
	United States			International
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount rate	4.14	%	4.90%	3.57	%	4.59%	4.32	%	5.26	%
Long-term rate of return on plan assets	7.30	%	7.75%	5.39	%	5.91%	7.30	%	7.75	%
Long-term rate of compensation increase	3.50	%	4.00%	2.80	%	2.87%	—	%	—	%
ESOP growth rate	—%		—%	—%		—%	10.00	%	10.00	%
Medical cost trend rate of increase	—%		—%	—%		—%	7.50	%	8.00	%

The overall investment objective of the plans is to balance risk and return so that obligations to employees are met. The Company evaluates its long-term rate of return on plan assets on an annual basis. In determining the long-term rate of return, the Company considers the nature of the plans’ investments, an expectation for the plans’ investment strategies and the historical rates of return. The assumed rate of return as of December 31, 2012 for the U.S. plans was 7.30%. Average annual rates of return for the U.S. plans for the most recent 1-year, 5-year, 10-year, 15-year and 25-year periods were 13%, 4%, 8%, 6%, and 8%, respectively. Similar assessments were performed in determining rates of return on international pension plan assets to arrive at the Company’s 2012 weighted-average rate of return of 5.39%.

The medical cost trend rate of increase assumed in measuring the expected cost of benefits is projected to decrease from 7.5% in 2013 to 5.0% by 2018, remaining at 5.0% for the years thereafter. Changes in the assumed rate can have a significant effect on amounts reported. A 1% change in the assumed medical cost trend rate would have the following approximate effect:



	One percentage point
	Increase		Decrease
Accumulated postretirement benefit obligation	$	112	$	(91	)
Annual expense	9		(7		)

Plans with projected benefit obligations in excess of plan assets and plans with accumulated benefit obligations in excess of plan assets as of December 31 consist of the following:



	Years Ended December 31,
	2012		2011
Benefit Obligation Exceeds Fair Value of Plan Assets
Projected benefit obligation	$	3,112	$	2,770
Fair value of plan assets	2,080		1,809

Accumulated benefit obligation	2,855		2,525
Fair value of plan assets	2,044		1,773

Summarized information regarding the net periodic benefit costs for the Company’s defined benefit and other retiree benefit plans is as follows:



	Pension Benefits																			Other Retiree Benefits
	2012			2011			2010				2012			2011			2010			2012			2011			2010
	United States										International
Components of Net Periodic Benefit Cost
Service cost	$	24		$	24		$	42			$	12		$	19		$	17		$	11		$	12		$	13
Interest cost	97			100			94				35			36			35			40			39			38
Annual ESOP allocation	—			—			—				—			—			—			(2		)	(2		)	(6		)
Expected return on plan assets	(112		)	(110		)	(99		)		(26		)	(27		)	(26		)	(3		)	(3		)	(2		)
Amortization of transition & prior service costs (credits)	9			9			5				2			3			3			3			2			1
Amortization of actuarial loss	62			46			52				9			9			9			18			16			19
Net periodic benefit cost	$	80		$	69		$	94			$	32		$	40		$	38		$	67		$	64		$	63
Other postretirement charges	—			—			23				9			3			1			1			1			8
Total pension cost	$	80		$	69		$	117			$	41		$	43		$	39		$	68		$	65		$	71
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount rate	4.90		%	5.30		%	5.75		%	⁽¹⁾	4.59		%	5.04		%	5.41		%	5.26		%	5.30		%	5.75		%	⁽¹⁾
Long-term rate of return on plan assets	7.75		%	8.00		%	8.00		%		5.91		%	6.23		%	6.58		%	7.75		%	8.00		%	8.00		%
Long-term rate of compensation increase	4.00		%	4.00		%	4.00		%		2.87		%	3.05		%	3.35		%	—		%	—		%	—		%
ESOP growth rate	—		%	—		%	—		%		—		%	—		%	—		%	10.00		%	10.00		%	10.00		%
Medical cost trend rate of increase	—		%	—		%	—		%		—		%	—		%	—		%	8.00		%	8.33		%	9.00		%

_______


⁽¹⁾	Effective with the plan amendments on September 1, 2010, the Company was required to remeasure the benefit obligations and plan assets of the affected plans, and a new discount rate of 4.75% was used to determine net periodic benefit cost through the end of 2011.

Other postretirement charges in 2012 primarily relate to the sale of land in Mexico. Other postretirement charges in 2010 primarily relate to one-time termination benefits incurred pursuant to a voluntary early retirement program for selected individuals in the U.S.

The Company made voluntary contributions of $101, $178 and $35 in 2012, 2011 and 2010, respectively, to its U.S. postretirement plans.

The estimated actuarial loss and the estimated transition/prior service cost for defined benefit and other retiree benefit plans that will be amortized from accumulated other comprehensive income into net periodic benefit cost over the next fiscal year is as follows:



	Pension Benefits		Other Retiree Benefits
Net actuarial loss	$	79	$	23
Net transition & prior service cost	11		—

Expected Contributions & Benefit Payments

Management’s best estimate of voluntary contributions to U.S. pension plans for the year ending December 31, 2013 is approximately $100. Actual funding may differ from current estimates depending on the variability of the market value of the assets as compared to the obligation and other market or regulatory conditions.

Total benefit payments to be paid to participants for the year ending December 31, 2013 from the Company’s assets are estimated to be approximately $94. Total benefit payments expected to be paid to participants from plan assets, or payments directly from the Company’s assets to participants in unfunded plans, are as follows:



	Pension Benefits
Years Ended December 31,	United States		International		Other Retiree Benefits		Total
2013	$	129	$	67	$	41	$	237
2014	128		50		42		220
2015	129		59		43		231
2016	129		54		44		227
2017	130		63		45		238
2018-2022	678		393		234		1,305

The entire disclosure for pension and other postretirement benefits.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI http://asc.fasb.org/topic&trid=2235017

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Implementation Guide (Q and A)
-Number FAS88
-Paragraph 63
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 106
-Paragraph 518
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 03-2
-Paragraph 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 87
-Paragraph 264
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph q
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph h
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 8
-Subparagraph m
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5, 6, 7, 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 158
-Paragraph 7, 21, 22
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS106-2
-Paragraph 20, 21, 22
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 30
-Paragraph 26
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Income Taxes

12 Months Ended

Dec. 31, 2012

Income Taxes

The components of income before income taxes are as follows for the three years ended December 31:



	2012		2011		2010
United States	$	1,155	$	1,098	$	1,252
International	2,719		2,691		2,178
Total Income before income taxes	$	3,874	$	3,789	$	3,430

The provision for income taxes consists of the following for the three years ended December 31:



	2012		2011		2010
United States	$	395	$	360	$	427
International	848		875		690
Total Provision for income taxes	$	1,243	$	1,235	$	1,117

Temporary differences between accounting for financial statement purposes and accounting for tax purposes result in the current provision for taxes being higher (lower) than the total provision for income taxes as follows:



	2012			2011			2010
Goodwill and intangible assets	$	(7	)	$	(1	)	$	(11	)
Property, plant and equipment	(13		)	(19		)	(29		)
Pension and other retiree benefits	(14		)	(47		)	4
Stock-based compensation	5			11			12
Tax loss and tax credit carryforwards	(39		)	(14		)	(28		)
Other, net	32			32			123
Total deferred tax provision	$	(36	)	$	(38	)	$	71

In 2010, Other, net includes a non-recurring tax benefit related to the reorganization of an overseas subsidiary.

The difference between the statutory U.S. federal income tax rate and the Company’s global effective tax rate as reflected in the Consolidated Statements of Income is as follows:



Percentage of Income before income taxes	2012		2011		2010
Tax at United States statutory rate	35.0	%	35.0	%	35.0	%
State income taxes, net of federal benefit	0.7		0.4		1.1
Earnings taxed at other than United States statutory rate	(2.6	)	(1.7	)	(4.6	)
Venezuela hyperinflationary transition charge	—		—		2.8
Other, net	(1.0	)	(1.1	)	(1.7	)
Effective tax rate	32.1	%	32.6	%	32.6	%

The components of deferred tax assets (liabilities) are as follows at December 31:



	2012			2011
Deferred tax liabilities:
Goodwill and intangible assets	$	(476	)	$	(471	)
Property, plant and equipment	(365		)	(345		)
Other	(162		)	(104		)
	(1,003		)	(920		)
Deferred tax assets:
Pension and other retiree benefits	544			480
Tax loss and tax credit carryforwards	61			105
Accrued liabilities	208			176
Stock-based compensation	113			115
Other	151			111
	1,077			987
Net deferred income taxes	$	74		$	67



	2012			2011
Deferred taxes included within:
Assets:
Other current assets	$	275		$	204
Deferred income taxes	92			115
Liabilities:
Deferred income taxes	(293		)	(252		)
Net deferred income taxes	$	74		$	67

Applicable U.S. income and foreign withholding taxes have not been provided on approximately $4,300 of undistributed earnings of foreign subsidiaries at December 31, 2012. These earnings have been and currently are considered to be indefinitely reinvested outside of the U.S. and currently are not subject to such taxes. Determining the tax liability that would arise if these earnings were remitted is not practicable.

In addition, net tax benefits of $80 in 2012, $79 in 2011 and $124 in 2010 recorded directly through equity predominantly include current and future tax benefits related to employee equity compensation and benefit plans.

The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return.

Unrecognized tax benefits activity for the years ended December 31, 2012, 2011 and 2010 is summarized below:



	2012			2011			2010
Unrecognized tax benefits:
Balance, January 1	$	176		$	171		$	187
Increases as a result of tax positions taken during the current year	34			76			38
Decreases of tax positions taken during prior years	(6		)	(46		)	(63		)
Increases of tax positions taken during prior years	10			10			16
Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations	(3		)	(30		)	(3		)
Effect of foreign currency rate movements	1			(5		)	(4		)
Balance, December 31	$	212		$	176		$	171

If all of the unrecognized tax benefits for 2012 above were recognized, approximately $165 would impact the effective tax rate. Although it is possible that the amount of unrecognized benefits with respect to our uncertain tax positions will increase or decrease in the next 12 months, the Company does not expect material changes.

The Company recognized approximately $5, $0 and ($4) of interest (income) expense related to the above unrecognized tax benefits within income tax expense in 2012, 2011 and 2010, respectively. The Company had accrued interest of approximately $19 and $15 as of December 31, 2012 and 2011, respectively.

The Company and its subsidiaries file U.S. federal income tax returns as well as income tax returns in many state and foreign jurisdictions. All U.S. federal income tax returns through December 31, 2007 have been audited by the IRS and there are limited matters in administrative appeals for years 2002 through 2007, the settlement of which is not expected to have a material adverse effect on the Company’s results of operations, cash flows or financial condition. With a few exceptions, the Company is no longer subject to U.S., state and local income tax examinations for the years prior to 2007. In addition, the Company has subsidiaries in various foreign jurisdictions that have statutes of limitations for tax audits generally ranging from three to six years.

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 136, 172
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 43, 44, 45, 46, 47, 48, 49
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Earnings Per Share

12 Months Ended

Dec. 31, 2012

Earnings Per Share



	For the Year Ended 2012					For the Year Ended 2011					For the Year Ended 2010
	Income		Shares (millions)	Per Share		Income		Shares (millions)	Per Share		Income			Shares (millions)	Per Share
Net income attributable to Colgate-Palmolive Company	$	2,472				$	2,431				$	2,203
Preferred dividends	—					—					(34		)
Basic EPS	2,472		476.1	$	5.19	2,431		488.3	$	4.98	2,169			487.8	$	4.45
Stock options and restricted stock			4.0					3.7						3.3
Convertible preference stock	—		—			—		—			34			19.8
Diluted EPS	$	2,472	480.1	$	5.15	$	2,431	492.0	$	4.94	$	2,203		510.9	$	4.31

Basic earnings per common share is computed by dividing net income available for common stockholders by the weighted-average number of common shares outstanding for the period.

Diluted earnings per common share is computed using the treasury stock method on the basis of the weighted-average number of shares of common stock plus the dilutive effect of potential common shares outstanding during the period. Dilutive potential common shares include outstanding stock options and restricted stock awards.

As of December 31, 2012, 2011 and 2010, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 1,752,304, 1,531,768 and 67,565, respectively.

As a result of rules issued by the IRS related to employer stock held in defined contribution plans, the Company issued a notice of redemption with respect to the 2,405,192 shares of preference stock outstanding on December 29, 2010. At the direction of the Company’s ESOP trustee, the shares of preference stock were converted into 19,241,536 shares of common stock.

Commitments and Contingencies

12 Months Ended

Dec. 31, 2012

Commitments and Contingencies

Minimum rental commitments under noncancellable operating leases, primarily for office and warehouse facilities, are $192 in 2013, $159 in 2014, $143 in 2015, $123 in 2016, $110 in 2017 and $428 thereafter. Rental expense amounted to $228 in 2012, $245 in 2011 and $220 in 2010. Capital leases included in fixed assets, contingent rentals and sublease income are not significant. The Company has various contractual commitments to purchase raw, packaging and other materials totaling approximately $806 at December 31, 2012.

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, environmental and tax matters. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

As a matter of course, the Company is regularly audited by the Internal Revenue Service (IRS) and other tax authorities around the world in countries where it conducts business. In this regard, all U.S. federal income tax returns through December 31, 2007 have been audited by the IRS and there are limited matters in administrative appeals for years 2002 through 2007, the settlement of which is not expected to have a material adverse effect on the Company’s results of operations, cash flows or financial condition. With a few exceptions, the Company is no longer subject to U.S., state and local income tax examinations for the years prior to 2007. In addition, the Company has subsidiaries in various foreign jurisdictions that have statutes of limitations for tax audits generally ranging from three to six years. Incremental tax payments related to potential disallowances for subsequent periods are not expected to be material.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $225 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company from the matters in question. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more of these matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.

Brazilian Matters

In 2001, the Central Bank of Brazil sought to impose a substantial fine on the Company’s Brazilian subsidiary based on alleged foreign exchange violations in connection with the financing of the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (formerly American Home Products) (the Seller), as described in the Company’s Form 8-K dated January 10, 1995. The Company appealed the imposition of the fine to the Brazilian Monetary System Appeals Council (the Council), and on January 30, 2007, the Council decided the appeal in the Company’s favor, dismissing the fine entirely. However, certain tax and civil proceedings that began as a result of this Central Bank matter are still outstanding as described below.

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, at the current exchange rate, approximate $130. The Company has been disputing the disallowances by appealing the assessments within the internal revenue authority’s appellate process with the following results to date:


▪	In June 2005, the First Board of Taxpayers ruled in the Company’s favor and allowed all of the previously claimed deductions for 1996 through 1998. In March 2007, the First Board of Taxpayers ruled in the Company’s favor and allowed all of the previously claimed deductions for 1999 through 2001. The tax authorities appealed these decisions to the next administrative level.


▪	In August 2009, the First Taxpayers’ Council (the next and final administrative level of appeal) overruled the decisions of the First Board of Taxpayers, upholding the majority of the assessments, disallowing a portion of the assessments and remanding a portion of the assessments for further consideration by the First Board of Taxpayers.

The Company has filed a motion for clarification with a special appeals chamber of the Taxpayers’ Council and further appeals are available within the Brazilian federal courts. The Company intends to challenge these assessments vigorously. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel and other advisors, that the disallowances are without merit and that the Company should ultimately prevail on appeal, if necessary, in the Brazilian federal courts.

In 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company intends to challenge this action vigorously.

In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest and penalties of approximately $78, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company is disputing the assessment within the internal revenue authority’s administrative appeals process. In October 2007, the Second Board of Taxpayers, which has jurisdiction over these matters, ruled in favor of the internal revenue authority. In January 2008, the Company appealed this decision, and in January 2012, a special appeals chamber of the Taxpayers’ Council denied the Company’s appeal. Although there can be no assurances, management believes, based on the advice of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should prevail on appeal, if not at the administrative level, in the Brazilian federal courts. The Company intends to challenge this assessment vigorously.

European Competition Matters

Since February 2006, the Company has learned that investigations relating to potential competition law violations involving the Company’s subsidiaries had been commenced by governmental authorities in a number of European countries. The Company understands that substantially all of these investigations also involve other consumer goods companies and/or retail customers. The status of the various pending matters is discussed below.

Fines have been imposed on the Company in the following matters, although the Company is appealing these fines:


▪	In December 2009, the Swiss competition law authority imposed a fine of $6 on the Company’s GABA subsidiary for alleged violations of restrictions on parallel imports into Switzerland. The Company is appealing the fine in the Swiss courts.


▪	In January 2010, the Spanish competition law authority found that four suppliers of shower gel had entered into an agreement regarding product down-sizing, for which Colgate’s Spanish subsidiary was fined $3. The Company is appealing the fine in the Spanish courts.


▪	In December 2010, the Italian competition law authority found that 16 consumer goods companies, including the Company’s Italian subsidiary, exchanged competitively sensitive information in the cosmetics sector, for which the Company’s Italian subsidiary was fined $3. The Company is appealing the fine in the Italian courts.


▪	In December 2011, the French competition law authority found that four consumer goods companies had entered into agreements on pricing and promotion of heavy duty detergents for which Colgate’s French subsidiary was fined $46 in connection with a divested business. The Company is appealing the fine in the French courts.


▪	In March 2012, the French competition law authority found that three pet food producers, including the Company’s Hill’s France subsidiary, had violated the competition law, for which it imposed a fine of $7 on the Company’s Hill’s France subsidiary for alleged restrictions on exports from France. The Company is appealing the fine in the French courts.

Currently, formal claims of violations, or statements of objections, are pending against the Company as follows:


▪	The German competition law authority has alleged that 17 branded goods companies, including the Company’s German subsidiary, exchanged sensitive information related to the German market. The Company has responded to this formal claim of violations.


▪	The Belgian competition law authority has alleged that 11 branded goods companies, including the Company’s Belgian subsidiary, assisted retailers to coordinate their retail prices on the Belgian market. The Company is in the process of responding to this statement of objections.

Investigations are ongoing in France and Greece, but no formal claims of violations have been filed in these jurisdictions except in the two French matters noted above.

The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The Company has undertaken a comprehensive review of its selling practices and related competition law compliance in Europe and elsewhere and, where the Company has identified a lack of compliance, it has undertaken remedial action. Competition and antitrust law investigations often continue for several years and can result in substantial fines for violations that are found. While the Company cannot predict the final financial impact of these competition law issues as these matters may change, the Company regularly evaluates developments in these matters and accrues liabilities as and when appropriate.

ERISA Matters

In October 2007, a putative class action claiming that certain aspects of the cash balance portion of the Colgate-Palmolive Company Employees’ Retirement Income Plan (the Plan) do not comply with the Employee Retirement Income Security Act was filed against the Plan and the Company in the United States District Court for the Southern District of New York. Specifically, Proesel, et al. v. Colgate-Palmolive Company Employees’ Retirement Income Plan, et al. alleges improper calculation of lump sum distributions, age discrimination and failure to satisfy minimum accrual requirements, thereby resulting in the underpayment of benefits to Plan participants. Two other putative class actions filed earlier in 2007, Abelman, et al. v. Colgate-Palmolive Company Employees’ Retirement Income Plan, et al., in the United States District Court for the Southern District of Ohio, and Caufield v. Colgate-Palmolive Company Employees’ Retirement Income Plan, in the United States District Court for the Southern District of Indiana, both alleging improper calculation of lump sum distributions and, in the case of Abelman, alleging failure to satisfy minimum accrual requirements, were transferred to the Southern District of New York and consolidated with Proesel into one action, In re Colgate-Palmolive ERISA Litigation. The complaint in the consolidated action alleges improper calculation of lump sum distributions and failure to satisfy minimum accrual requirements, but does not include a claim for age discrimination. The relief sought includes recalculation of benefits in unspecified amounts, pre- and post-judgment interest, injunctive relief and attorneys’ fees. This action has not been certified as a class action as yet. The parties are in discussions via non-binding mediation to determine whether the action can be settled. The Company and the Plan intend to contest this action vigorously should the parties be unable to reach a settlement.

The entire disclosure for commitments and contingencies.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 14
-Paragraph 3
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 9, 10, 11, 12
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Venezuela	12 Months Ended
Venezuela	Dec. 31, 2012
Notes to Financial Statements [Abstract]
Venezuela	Venezuela Effective January 1, 2010, Venezuela was designated as hyperinflationary and, therefore, the functional currency for the Company’s Venezuelan subsidiary (CP Venezuela) became the U.S. dollar. As a result, the impact of Venezuelan currency fluctuations is reported in income. The change in the reporting currency from the Venezuelan bolivar fuerte to the U.S. dollar resulted in a one-time charge of $271 recorded within Other (income) expense, net in the first quarter of 2010. On January 8, 2010, the Venezuelan government announced its decision to devalue its currency and implement a two-tier exchange rate structure. As a result, the official exchange rate changed from 2.15 to 2.60 for essential goods and 4.30 for non-essential goods. The devaluation resulted in a one-time pretax gain of $46 recorded in Other (income) expense and an aftertax gain of $59 in the first quarter of 2010. In December 2010, the Venezuelan government announced that, effective January 1, 2011, the 2.60 exchange rate for essential goods would be abolished. As a result, CP Venezuela incurred an aftertax loss of $36 in the fourth quarter of 2010. The Company remeasures the financial statements of CP Venezuela at the rate at which it expects to remit future dividends, which was 4.30 for the years 2010, 2011 and 2012. For the year ended December 31, 2012, CP Venezuela represented approximately 5% of the Company’s consolidated Net sales. On February 8, 2013, the Venezuelan government announced its intention to devalue its currency, and effective February 9, 2013 the official exchange rate changed from 4.30 to 6.30 per dollar. This devaluation had no impact on the Company's 2012 Consolidated Financial Statements. The Company's preliminary assessment of the one-time impact of the devaluation is that the Company will incur an aftertax loss of approximately $120 ($0.25 per common share) in the first quarter of 2013, related to the remeasurement of the local balance sheet at the date of the devaluation. We will remeasure the financial statements of CP Venezuela for 2013 at 6.30, the rate at which we now expect to remit dividends. As the local currency operations in Venezuela will now translate into fewer U.S. dollars, this will have an ongoing adverse effect on our reported results. Following the February 2013 devaluation, CP Venezuela's bolivar fuerte-denominated net monetary asset position, which would be subject to remeasurement in the event of a further devaluation, was reduced to approximately $390 as compared to approximately $520 at December 31, 2012. These amounts do not include $255 of devaluation-protected bonds issued by the Venezuelan government, as these bonds provide protection against devaluations by adjusting the amount of bolivares fuerte received at maturity for any devaluation subsequent to issuance.

Segment Information

12 Months Ended

Dec. 31, 2012

Segment Information

The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. The operations of the Oral, Personal and Home Care segment are managed geographically in four reportable operating segments: North America, Latin America, Europe/South Pacific and Greater Asia/Africa. Management evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of the operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes.

The accounting policies of the operating segments are generally the same as those described in Note 2. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock awards, research and development costs, Corporate overhead costs, restructuring and related implementation costs, and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the business segments.

In 2012, Corporate Operating profit (loss) includes charges of $89 related to the 2012 Restructuring Program, costs of $21 associated with the business realignment and other cost-saving initiatives, and costs of $24 related to the sale of land in Mexico. In 2011, Corporate Operating profit (loss) included a gain on the sale of the non-core laundry detergent business in Colombia of $207, costs of $190 associated with the business realignment and other cost-saving initiatives, costs of $13 related to the sale of land in Mexico, and a charge of $21 for a competition law matter in France related to a divested detergent business. The business realignment and other cost-saving initiatives include the integration of Sanex, the right-sizing of the Colombia business and the closing of an oral care facility in Mississauga, Canada and a Hill’s facility in Los Angeles, California. For further information regarding the sale of land in Mexico and the sale of the non-core laundry detergent business in Colombia, refer to Note 3. In 2010, Corporate Operating profit (loss) included a one-time $271 charge for the transition to hyperinflationary accounting in Venezuela as of January 1, 2010, a fourth quarter $86 pretax charge for termination benefits and a fourth quarter $50 pretax gain on sale of non-core product lines. For further information regarding Venezuela, refer to Note 14.



	2012		2011		2010
Net sales
Oral, Personal and Home Care
North America⁽¹⁾	$	3,096	$	2,995	$	3,005
Latin America	4,907		4,778		4,261
Europe/South Pacific	3,417		3,508		3,220
Greater Asia/Africa	3,505		3,281		2,998
Total Oral, Personal and Home Care	14,925		14,562		13,484
Pet Nutrition⁽²⁾	2,160		2,172		2,080
Total Net sales	$	17,085	$	16,734	$	15,564

_________


⁽¹⁾	Net sales in the U.S. for Oral, Personal and Home Care were $2,669, $2,567 and $2,591 in 2012, 2011 and 2010, respectively.


⁽²⁾	Net sales in the U.S. for Pet Nutrition were $1,052, $1,032 and $1,025 in 2012, 2011 and 2010, respectively.



	2012			2011			2010
Operating profit
Oral, Personal and Home Care
North America	$	834		$	791		$	884
Latin America	1,430			1,414			1,295
Europe/South Pacific	747			715			742
Greater Asia/Africa	886			807			767
Total Oral, Personal and Home Care	3,897			3,727			3,688
Pet Nutrition	589			560			559
Corporate	(597		)	(446		)	(758		)
Total Operating profit	$	3,889		$	3,841		$	3,489



	2012		2011		2010
Capital expenditures
Oral, Personal and Home Care
North America	$	43	$	54	$	57
Latin America	237		194		138
Europe/South Pacific	71		64		80
Greater Asia/Africa	104		119		111
Total Oral, Personal and Home Care	455		431		386
Pet Nutrition	37		32		81
Corporate	73		74		83
Total Capital expenditures	$	565	$	537	$	550



	2012		2011		2010
Depreciation and amortization
Oral, Personal and Home Care
North America	$	51	$	57	$	57
Latin America	90		91		84
Europe/South Pacific	85		82		67
Greater Asia/Africa	81		79		69
Total Oral, Personal and Home Care	307		309		277
Pet Nutrition	50		51		45
Corporate	68		61		54
Total Depreciation and amortization	$	425	$	421	$	376



Identifiable assets	2012		2011		2010
Oral, Personal and Home Care
North America	$	2,195	$	2,288	$	2,231
Latin America	4,250		3,636		3,092
Europe/South Pacific	3,649		3,555		2,775
Greater Asia/Africa	2,169		2,069		1,943
Total Oral, Personal and Home Care	12,263		11,548		10,041
Pet Nutrition	1,045		1,078		1,081
Corporate⁽³⁾	86		98		50
Total Identifiable assets⁽⁴⁾	$	13,394	$	12,724	$	11,172

____________


⁽³⁾	In 2012, Corporate identifiable assets primarily consist of derivative instruments (67%) and investments in equity securities (28%). In 2011, Corporate identifiable assets primarily consist of derivative instruments (73%) and investments in equity securities (22%). In 2010, Corporate identifiable assets primarily consist of derivative instruments (44%) and investments in equity securities (48%).


⁽⁴⁾	Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $8,066, $7,926 and $7,116 in 2012, 2011 and 2010, respectively.

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 131
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Supplemental Income Statement Information

12 Months Ended

Dec. 31, 2012

Supplemental Income Statement Information



Other (income) expense, net	2012			2011			2010
Amortization of intangible assets	31			$	28		$	22
2012 Restructuring Program	81			—			—
Costs related to the sale of land in Mexico	—			13			—
Business realignment and other cost-saving initiatives	2			136			—
Gain on sales of non-core product lines	—			(207		)	(50		)
Charge for a French competition law matter	—			21			—
Sanex acquisition transaction costs	—			12			—
Venezuela hyperinflationary transition charge	—			—			271
Gain from remeasurement of Venezuelan balance sheet	—			—			(10		)
Termination benefits	—			—			86
Legal and environmental matters	7			11			(3		)
Asset impairments	—			—			5
Equity (income)	(7		)	(6		)	(5		)
Other, net	(1		)	(17		)	(15		)
Total Other (income) expense, net	$	113		$	(9	)	$	301



Interest expense, net	2012			2011			2010
Interest incurred	$	81		$	59		$	69
Interest capitalized	(1		)	(1		)	(4		)
Interest income	(65		)	(6		)	(6		)
Total Interest expense, net	$	15		$	52		$	59



	2012		2011		2010
Research and development	$	259	$	262	$	256
Advertising	$	1,792	$	1,734	$	1,656

Supplemental Balance Sheet Information

12 Months Ended

Dec. 31, 2012

Supplemental Balance Sheet Information

Inventories by major class are as follows:



Inventories	2012		2011
Raw materials and supplies	$	362	$	319
Work-in-process	81		54
Finished goods	922		954
Total Inventories	$	1,365	$	1,327

Inventories valued under LIFO amounted to $268 and $271 at December 31, 2012 and 2011, respectively. The excess of current cost over LIFO cost at the end of each year was $37 and $30, respectively. The liquidations of LIFO inventory quantities had no material effect on income in 2012, 2011 and 2010.



Property, plant and equipment, net	2012			2011
Land	$	251		$	240
Buildings	1,439			1,342
Manufacturing machinery and equipment	4,987			4,673
Other equipment	1,144			1,069
	7,821			7,324
Accumulated depreciation	(3,979		)	(3,656		)
Total Property, plant and equipment, net	$	3,842		$	3,668



Other accruals	2012		2011
Accrued advertising and coupon redemption	$	646	$	555
Accrued payroll and employee benefits	345		293
Accrued taxes other than income taxes	48		35
Restructuring accrual	89		—
Pension and other retiree benefits	86		84
Accrued interest	26		22
Derivatives	10		6
Other	638		705
Total Other accruals	$	1,888	$	1,700



Other liabilities	2012		2011
Pension and other retiree benefits	$	1,786	$	1,582
Other	263		203
Total Other liabilities	$	2,049	$	1,785

Supplemental Comprehensive Income Information

12 Months Ended

Dec. 31, 2012

Other Comprehensive Income (Loss), Net of Tax [Abstract]

Supplemental Comprehensive Income Information

Other Comprehensive Income components attributable to Colgate-Palmolive Company before tax and net of tax during the years ended December 31 were as follows:



	2012						2011						2010
	Pre-tax			Net of Tax			Pre-tax			Net of Tax			Pre-tax			Net of Tax

Cumulative translation adjustments	$	18		$	(20	)	$	(291	)	$	(298	)	$	166		$	162
Pension and other benefits:
Net actuarial loss and prior service costs arising during the period	(317		)	(207		)	(249		)	(163		)	(309		)	(196		)
Amortization of net actuarial loss, transition and prior service costs	101			62			85			55			89			53
Retirement Plan and other retiree benefit adjustments	(216		)	(145		)	(164		)	(108		)	(220		)	(143		)
Available-for-sale securities:
Unrealized gains (losses) on available- for-sale securities	28			18			60			46			(8		)	(8		)
Reclassification of (gains) losses into net earnings on available- for-sale securities	—			—			—			—			(36		)	(29		)
Gains (losses) on available-for sale securities	28			18			60			46			(44		)	(37		)
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	13			8			(10		)	(7		)	2			2
Reclassification of (gains) losses into net earnings on cash flow hedges	(11		)	(7		)	9			7			(4		)	(3		)
Gains (losses) on cash flow hedges	2			1			(1		)	—			(2		)	(1		)
Total Other comprehensive income	$	(168	)	$	(146	)	$	(396	)	$	(360	)	$	(100	)	$	(19	)

There were no tax impacts on Other comprehensive income attributable to Noncontrolling interests.

Accumulated Other Comprehensive Income

Accumulated other comprehensive income is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs, unrealized gains and losses from derivative instruments designated as cash flow hedges and unrealized gains and losses on available for sale securities. At December 31, 2012 and 2011, Accumulated other comprehensive income consisted primarily of aftertax unrecognized pension and other retiree benefit costs of $1,053 and $908, respectively, and cumulative foreign currency translation adjustments of $1,609 and $1,589, respectively. Foreign currency translation adjustments in 2012 primarily reflect gains from the Mexican peso and the Swiss franc, which were partially offset by losses from the Brazilian real. In 2012, foreign currency translation adjustments were also impacted by deferred tax related to intercompany loans considered to be long-term in nature. Foreign currency translation adjustments in 2011 primarily reflect losses due to the weakening of the Brazilian real, the Mexican peso and the Euro.

The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e689-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=20435746&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e716-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e640-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e709-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e637-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Reclassification Adjustments
-URI http://asc.fasb.org/extlink&oid=6522872

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e681-108580

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 14-26
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Quarterly Financial Data (Unaudited)

12 Months Ended

Dec. 31, 2012

Quarterly Financial Data (Unaudited)



	Total			First Quarter			Second Quarter			Third Quarter			Fourth Quarter
2012
Net sales	$	17,085		$	4,200		$	4,267		$	4,332		$	4,286
Gross profit	9,932		⁽¹⁾	2,437		⁽³⁾	2,461		⁽⁵⁾	2,529		⁽⁷⁾	2,505		⁽⁹⁾
Net income including noncontrolling interests	2,631		⁽²⁾	633		⁽⁴⁾	665		⁽⁶⁾	697		⁽⁸⁾	636		⁽¹⁰⁾
Net income attributable to Colgate-Palmolive Company	2,472		⁽²⁾	593		⁽⁴⁾	627		⁽⁶⁾	654		⁽⁸⁾	598		⁽¹⁰⁾
Earnings per common share:
Basic	5.19		⁽²⁾	1.24		⁽⁴⁾	1.31		⁽⁶⁾	1.38		⁽⁸⁾	1.27		⁽¹⁰⁾
Diluted	5.15		⁽²⁾	1.23		⁽⁴⁾	1.30		⁽⁶⁾	1.36		⁽⁸⁾	1.26		⁽¹⁰⁾

2011
Net sales	$	16,734		$	3,994		$	4,185		$	4,383		$	4,172
Gross profit	9,590		⁽¹¹⁾	2,331			2,404			2,462		⁽¹³⁾	2,393		⁽¹⁵⁾
Net income including noncontrolling interests	2,554		⁽¹²⁾	607			646			676		⁽¹⁴⁾	625		⁽¹⁶⁾
Net income attributable to Colgate-Palmolive Company	2,431		⁽¹²⁾	576			622			643		⁽¹⁴⁾	590		⁽¹⁶⁾
Earnings per common share:
Basic	4.98		⁽¹²⁾	1.17			1.27			1.32		⁽¹⁴⁾	1.22		⁽¹⁶⁾
Diluted	4.94		⁽¹²⁾	1.16			1.26			1.31		⁽¹⁴⁾	1.21		⁽¹⁶⁾

____________


Note:	Basic and diluted earnings per share are computed independently for each quarter presented. Accordingly, the sum of the quarterly earnings per common share may not agree with the calculated full year earnings per common share.


⁽¹⁾	Gross profit for the full year of 2012 includes $2 of charges related to the 2012 Restructuring Program, $24 of costs related to the sale of land in Mexico and $5 of costs associated with the business realignment and other cost-saving initiatives.


⁽²⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2012 include $70 of aftertax charges related to the 2012 Restructuring Program, $18 of aftertax costs related to the sale of land in Mexico and $14 of aftertax costs associated with the business realignment and other cost-saving initiatives.


⁽³⁾	Gross profit for the first quarter of 2012 includes $7 of costs related to the sale of land in Mexico and $2 of costs associated with the business realignment and other cost-saving initiatives.


⁽⁴⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the first quarter of 2012 include $5 of aftertax costs related to the sale of land in Mexico and $3 of aftertax costs associated with the business realignment and other cost-saving initiatives.


⁽⁵⁾	Gross profit for the second quarter of 2012 includes $6 of costs related to the sale of land in Mexico and $2 of costs associated with the business realignment and other cost-saving initiatives.


⁽⁶⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the second quarter of 2012 include $5 of aftertax costs related to the sale of land in Mexico and $9 of aftertax costs associated with the business realignment and other cost-saving initiatives.


⁽⁷⁾	Gross profit for the third quarter of 2012 includes $7 of costs related to the sale of land in Mexico and $1 of costs associated with the business realignment and other cost-saving initiatives.


⁽⁸⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the third quarter of 2012 include $5 of aftertax costs related to the sale of land in Mexico and $2 of aftertax costs associated with the business realignment and other cost-saving initiatives.


⁽⁹⁾	Gross profit for the fourth quarter of 2012 includes $2 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.


⁽¹⁰⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the fourth quarter of 2012 include $70 of aftertax charges related to the 2012 Restructuring Program and $3 of aftertax costs related to the sale of land in Mexico.


⁽¹¹⁾	Gross profit for the full year of 2011 includes $44 of costs associated with the business realignment and other cost-saving initiatives.

⁽¹²⁾


⁽¹³⁾	Gross profit for the third quarter of 2011 includes $28 of costs associated with the business realignment and other cost-saving initiatives.

⁽¹⁴⁾

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the third quarter of 2011 include a $135 aftertax gain resulting from the sale of the non-core laundry detergent business in Colombia, $128 of aftertax costs associated with the business realignment and other cost-saving initiatives and $5 of aftertax costs related to the sale of land in Mexico.


⁽¹⁵⁾	Gross profit for the fourth quarter of 2011 includes $16 of costs associated with the business realignment and other cost-saving initiatives.

⁽¹⁶⁾

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the fourth quarter of 2011 includes $19 of aftertax costs associated with the business realignment and other cost-saving initiatives, $4 of aftertax costs related to the sale of land in Mexico and a $21 charge for a competition law matter in France related to a divested detergent business.

The entire disclosure for the quarterly financial data in the annual financial statements. The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.

Schedule II - Valuation and Qualifying Accounts [Abstract]

Schedule II - Valuation and Qualifying Accounts

12 Months Ended

Dec. 31, 2012

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS



Column A	Column B		Column C				Column D			Column E
			Additions
	Balance at Beginning of Period		Charged to Costs and Expenses		Other		Deductions			Balance at End of Period
Year Ended December 31, 2012
Allowance for doubtful accounts and estimated returns	$	49	$	18	$	—	$	6		$	61
Valuation allowance for deferred tax assets	$	1	$	—	$	—	$	—		$	1

Year Ended December 31, 2011
Allowance for doubtful accounts and estimated returns	$	53	$	6	$	—	$	10		$	49
Valuation allowance for deferred tax assets	$	1	$	—	$	—	$	—		$	1

Year Ended December 31, 2010
Allowance for doubtful accounts and estimated returns	$	52	$	1	$	—	$	—		$	53
Valuation allowance for deferred tax assets	$	2	$	—	$	—	$	1	⁽¹⁾	$	1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Dec. 31, 2012
Notes to Financial Statements [Abstract]
Principles of Consolidation	Principles of Consolidation The Consolidated Financial Statements include the accounts of Colgate-Palmolive Company and its majority-owned or controlled subsidiaries. Intercompany transactions and balances have been eliminated. The Company’s investments in consumer products companies with interests ranging between 20% and 50%, where the Company has significant influence over the investee, are accounted for using the equity method. Net income (loss) from such investments is recorded in Other (income) expense, net in the Consolidated Statements of Income. As of December 31, 2012 and 2011, equity method investments included in Other assets in the Consolidated Balance Sheets were $25 and $20, respectively. Unrelated third parties hold the remaining ownership interests in these investments. Investments with less than a 20% interest are accounted for using the cost method.
Use of Estimates	Use of Estimates The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to use judgment and make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. As such, the most significant uncertainty in the Company’s assumptions and estimates involved in preparing the financial statements includes pension and other retiree benefit cost assumptions, stock-based compensation, asset impairment, uncertain tax positions, tax valuation allowances and legal and other contingency reserves. Additionally, the Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments and retirement plan assets. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. Actual results could ultimately differ from those estimates.
Revenue Recognition	Revenue Recognition Sales are recorded at the time products are shipped to trade customers and when risk of ownership transfers. Net sales reflect units shipped at selling list prices reduced by sales returns and the cost of current and continuing promotional programs. Current promotional programs, such as product listing allowances and co-operative advertising arrangements, are recorded in the period incurred. Continuing promotional programs are predominantly consumer coupons and volume-based sales incentive arrangements with trade customers. The redemption cost of consumer coupons is based on historical redemption experience and is recorded when coupons are distributed. Volume-based incentives offered to trade customers are based on the estimated cost of the program and are recorded as products are sold.
Shipping and Handling Costs	Shipping and Handling Costs Shipping and handling costs are classified as Selling, general and administrative expenses and were $1,262, $1,250 and $1,142 for the years ended December 31, 2012, 2011 and 2010, respectively.
Marketing Costs	Marketing Costs The Company markets its products through advertising and other promotional activities. Advertising costs are included in Selling, general and administrative expenses and are expensed as incurred. Certain consumer and trade promotional programs, such as consumer coupons, are recorded as a reduction of sales.
Cash and Cash equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents.
Inventories	Inventories Inventories are stated at the lower of cost or market. The cost of approximately 80% of inventories is determined using the first-in, first-out (FIFO) method. The cost of all other inventories, predominantly in the U.S. and Mexico, is determined using the last-in, first-out (LIFO) method.
Property, Plant and Equipment	Property, Plant and Equipment Land, buildings and machinery and equipment are stated at cost. Depreciation is provided, primarily using the straight-line method, over estimated useful lives ranging from 3 to 15 years for machinery and equipment and up to 40 years for buildings. Depreciation attributable to manufacturing operations is included in Cost of sales. The remaining component of depreciation is included in Selling, general and administrative expenses.
Goodwill and Other Intangibles	Goodwill and Other Intangibles Goodwill and indefinite life intangible assets, such as the Company’s global brands, are subject to impairment tests at least annually. These tests were performed and did not result in an impairment charge. Other intangible assets with finite lives, such as local brands and trademarks, customer relationships and non-compete agreements, are amortized over their useful lives, generally ranging from 5 to 40 years. Amortization expense related to intangible assets is included in Other (income) expense, net, which is included in Operating profit.
Income Taxes	Income Taxes The provision for income taxes is determined using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized based upon the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates that will be in effect at the time such differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Provision is made currently for taxes payable on remittances of overseas earnings; no provision is made for taxes on overseas retained earnings that are deemed to be permanently reinvested. The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return. The Company recognizes interest expense and penalties related to unrecognized tax benefits within income tax expense.
Financial Instruments	Financial Instruments Derivative instruments are recorded as assets and liabilities at estimated fair value based on available market information. The Company’s derivative instruments that qualify for hedge accounting are designated as either fair value hedges, cash flow hedges or net investment hedges. For fair value hedges, changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, are recognized in earnings each period. For cash flow hedges, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) and are recognized in earnings when the offsetting effect of the hedged item is also recognized in earnings. For hedges of the net investment in foreign subsidiaries, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) to offset the change in the value of the net investment being hedged. Cash flows related to hedges are classified in the same category as the cash flows from the hedged item in the Consolidated Statements of Cash Flows. The Company may also enter into certain foreign currency and interest rate instruments that economically hedge certain of its risks but do not qualify for hedge accounting. Changes in fair value of these derivative instruments, based on quoted market prices, are recognized in earnings each period. The Company’s derivative instruments and other financial instruments are more fully described in Note 7, along with the related fair value measurement considerations.
Stock-Based Compensation	Stock-Based Compensation The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock, based on the fair value of those awards at the date of grant over the requisite service period. The Company uses the Black-Scholes-Merton (Black-Scholes) option pricing model to determine the fair value of stock option awards. Stock-based compensation plans, related expenses and assumptions used in the Black-Scholes option pricing model are more fully described in Note 8.
Currency Translation	Currency Translation The assets and liabilities of foreign subsidiaries, other than those operating in highly inflationary environments, are translated into U.S. dollars at year-end exchange rates with resulting translation gains and losses accumulated in a separate component of shareholders’ equity. Income and expense items are translated into U.S. dollars at average rates of exchange prevailing during the year. For subsidiaries operating in highly inflationary environments (currently, Venezuela), non-monetary assets, such as inventories, prepaid expenses, goodwill and property, plant and equipment are remeasured at their historical exchange rates, while monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these operations are included in Net income attributable to Colgate-Palmolive Company.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In February 2013, the FASB issued ASU No. 2013-02, "Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income." ASU No. 2013-02 requires presentation of reclassification adjustments from each component of accumulated other comprehensive income either in a single note or parenthetically on the face of the financial statements, for those amounts required to be reclassified into Net income in their entirety in the same reporting period. For amounts that are not required to be reclassified in their entirety in the same reporting period, cross-reference to other disclosures is required. As permitted under ASU 2013-02, the Company has elected to present reclassification adjustments from each component of accumulated other comprehensive income within a single note to the financial statements beginning the in first quarter of 2013. In June 2011, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2011-05, “Presentation of Comprehensive Income.” ASU No. 2011-05 eliminates the current option to disclose other comprehensive income and its components in the statement of changes in equity. As permitted under ASU No. 2011-05, the Company has elected to present items of Net income and Other comprehensive income in two separate consecutive statements beginning in the first quarter of 2012.
Reclassifications	Reclassifications Certain prior year amounts have been reclassified to conform to the current year presentation.

Nature of Operations (Tables)

12 Months Ended

Dec. 31, 2012

Percentage of worldwide sales

The Company’s principal classes of products accounted for the following percentages of worldwide Net sales for the past three years:



	2012		2011		2010
Oral Care	44	%	43	%	43	%
Personal Care	22	%	22	%	22	%
Home Care	21	%	22	%	22	%
Pet Nutrition	13	%	13	%	13	%
Total	100	%	100	%	100	%

Acquisitions and Divestitures (Tables)

12 Months Ended

Dec. 31, 2012

Schedule of Business Acquisitions, by Acquisition

Total purchase price consideration of $966 was allocated to the net assets acquired based on their respective fair values at June 20, 2011, as follows:



Recognized amounts of assets acquired and liabilities assumed:
Inventories	$	26
Property, plant and equipment, net	3
Other intangible assets, net	596
Goodwill, net	411
Accrued income taxes	(48		)
Long-term deferred income taxes	(18		)
Long-term other liabilities	(4		)
Fair value of net assets acquired	$	966

Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1486-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1392-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph F4
-Subparagraph e
-Appendix F

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 52
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Restructuring and Related Activities [Abstract]

Restructuring and Related Implementation Charges (Tables)

12 Months Ended

Dec. 31, 2012

Schedule of Restructuring and Related Costs

For the year ended December 31, 2012 restructuring and implementation-related charges are reflected in the income statement as follows:



	2012
Cost of sales	$	2
Selling, general and administrative expenses	6
Other (income) expense, net	81
Total 2012 Restructuring Program charges, pretax	$	89

Total 2012 Restructuring Program charges, aftertax	$	70

Schedule of Restructuring Reserve by Type of Cost

The following table summarizes the activity for the restructuring and implementation-related charges discussed above and the related accrual:



	Employee-Related Costs			Incremental Depreciation		Asset Impairments		Other			Total
Charges	$	78		$	—	$	—	$	11		$	89
Cash payments	(1		)	—		—		(4		)	(5		)
Charges against assets	—			—		—		—			—
Other	—			—		—		—			—
Foreign exchange	7			—		—		(2		)	5
Balance at December 31, 2012	$	84		$	—	$	—	$	5		$	89

Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2012

Schedule Of Finite And Indefinite Lived Intangible Assets By Major Class [Table]

Schedule of Goodwill

The net carrying value of Goodwill as of December 31, 2012 and 2011, by segment is as follows:



	2012		2011
Oral, Personal and Home Care
North America	$	374	$	370
Latin America	406		434
Europe/South Pacific	1,478		1,450
Greater Asia/Africa	227		225
Total Oral, Personal and Home Care	2,485		2,479
Pet Nutrition	15		15
Total Goodwill, net	$	2,500	$	2,494

Other intangible assets as of December 31, 2012 and 2011 are comprised of the following:



	2012							2011
	Gross Carrying Amount		Accumulated Amortization			Net		Gross Carrying Amount		Accumulated Amortization			Net
Trademarks	$	548	$	(254	)	$	294	$	536	$	(236	)	$	300
Other finite life intangible assets	212		(34		)	178		205		(18		)	187
Indefinite life intangible assets	1,027		—			1,027		1,017		—			1,017
Total Other intangible assets	$	1,787	$	(288	)	$	1,499	$	1,758	$	(254	)	$	1,504

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

Long-Term Debt and Credit Facilities Long-Term Debt and Credit Facilities (Tables)

12 Months Ended

Dec. 31, 2012

Schedule of Long-term Debt Instruments

Long-term debt consists of the following at December 31:



	Weighted Average Interest Rate		Maturities			2012		2011
Notes	2.1	%	2013	-	2078	$	4,733	$	4,089
Payable to banks	—	%	2013			—		16
Commercial paper	0.1	%	2013			443		671
						5,176		4,776
Less: Current portion of long-term debt						250		346
Total						$	4,926	$	4,430

Schedule of Maturities of Long-term Debt

Excluding commercial paper reclassified as long-term debt, scheduled maturities of long-term debt and capitalized leases outstanding as of December 31, 2012, are as follows:



Years Ended December 31,
2013	$	250
2014	887
2015	494
2016	254
2017	678
Thereafter	2,170

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6584090&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 22
-Article 5

Fair Value Measurements and Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2012

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at December 31, 2012 and December 31, 2011:



	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		12/31/12		12/31/11			12/31/12		12/31/11
Interest rate swap contracts	Other current assets	$	3	$	2	Other accruals	$	—	$	—
Interest rate swap contracts	Other assets	41		40		Other liabilities	—		2
Foreign currency contracts	Other current assets	7		8		Other accruals	10		6
Foreign currency contracts	Other assets	13		28		Other liabilities	—		—
Commodity contracts	Other current assets	1		—		Other accruals	—		1
Total designated		$	65	$	78		$	10	$	9

Derivatives not designated
Foreign currency contracts	Other assets	$	—	$	3	Other liabilities	$	1	$	—
Total not designated		$	—	$	3		$	1	$	—

Total derivative instruments		$	65	$	81		$	11	$	9

Other financial instruments
Marketable securities	Other current assets	$	116	$	72
Venezuelan bonds, long-term	Other assets	618		236
Total other financial instruments		$	734	$	308

Activity related to fair falue hedges

Activity related to fair value hedges recorded during each period presented was as follows:



	2012									2011
	Foreign Currency Contracts			Interest Rate Swaps			Total			Foreign Currency Contracts			Interest Rate Swaps			Total
Notional Value at December 31,	$	1,117		$	1,338		$	2,455		$	670		$	1,668		$	2,338
Gain (loss) on derivative	9			6			15			5			25			30
Gain (loss) on hedged items	(9		)	(6		)	(15		)	(5		)	(25		)	(30		)

Activity related to cash flow hedges

Activity related to cash flow hedges recorded during each period presented was as follows:



	2012						2011
	Foreign Currency Contracts		Commodity Contracts		Total		Foreign Currency Contracts			Commodity Contracts			Total
Notional Value at December 31,	$	398	$	23	$	421	$	403		$	32		$	435
Gain (loss) recognized in OCI	4		9		13		(9		)	(1		)	(10		)
Gain (loss) reclassified into Cost of sales	4		7		11		(13		)	4			(9		)

Activity related to net investment hedges recorded during each period presented was as follows:



	2012									2011
	Foreign Currency Contracts			Foreign Currency Debt			Total			Foreign Currency Contracts			Foreign Currency Debt			Total
Notional Value at December 31,	$	522		$	383		$	905		$	485		$	194		$	679
Gain (loss) on instruments	(11		)	(8		)	(19		)	8			1			9
Gain (loss) on hedged items	8			8			16			(8		)	(1		)	(9		)

Activity related to these contracts during each period presented was as follows:



	2012			2011
	Cross-currency Swap			Cross-currency Swap
Notional Value at December 31,	$	96		$	96
Gain (loss) on instrument	(4		)	(1		)
Gain (loss) on hedged item	4			1

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation



	2012		2011
Beginning balance as of January 1	$	236	$	96
Unrealized gain (loss) on investment	28		61
Purchases and sales during the period	378		79
Ending balance as of December 31	$	642	$	236

Capital Stock and Stock-Based Compensation Plans (Tables)

12 Months Ended

Dec. 31, 2012

Schedule Of Common And Treasury Stock Activity

A summary of common stock and treasury stock activity for the three years ended December 31, is as follows:



	Common Stock Outstanding		Treasury Stock
Balance, January 1, 2010	494,165,017		238,688,163

Common stock acquired	(25,401,785	)	25,401,785
Shares issued for stock options	4,233,775		(4,233,775	)
Shares issued for restricted stock and other	993,132		(993,132	)
Preference stock conversion	20,860,328		(20,860,328	)
Balance, December 31, 2010	494,850,467		238,002,713

Common stock acquired	(21,320,936	)	21,320,936
Shares issued for stock options	5,758,879		(5,758,879	)
Shares issued for restricted stock and other	729,665		(729,665	)
Balance, December 31, 2011	480,018,075		252,835,105

Common stock acquired	(19,365,301	)	19,365,301
Shares issued for stock options	6,108,615		(6,108,615	)
Shares issued for restricted stock and other	1,102,949		(1,102,949	)
Balance, December 31, 2012	467,864,338		264,988,842

Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions

Fair value is estimated using the Black-Scholes option pricing model with the assumptions summarized in the following table:



	2012		2011		2010
Expected Term of Options	4.5 years		4.5 years		4.5 years
Expected Volatility Rate	20.8	%	21.3	%	22.5	%
Risk-Free Rate	0.6	%	0.8	%	1.3	%
Expected Dividend Yield	2.4	%	2.6	%	2.8	%

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity

A summary of restricted stock award activity during 2012 is presented below:



	Shares (in thousands)		Weighted Average Grant Date Fair Value Per Award
Restricted stock awards as of January 1, 2012	3,037		$	76
Activity:
Granted	734		100
Vested	(1,062	)	66
Forfeited	(75	)	82
Restricted stock awards as of December 31, 2012	2,634		$	87

Schedule of Share-based Compensation, Stock Options, Activity

A summary of stock option plan activity during 2012 is presented below:



	Shares (in thousands)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)	Value of Unexercised In-the-Money Options
Options outstanding, January 1, 2012	22,294		$	76
Granted	5,261		104
Exercised	(6,217	)	68
Forfeited or expired	(167	)	85
Options outstanding, December 31, 2012	21,171		85		4	$	406
Options exercisable, December 31, 2012	11,635		$	77	3	$	322

Retirement Plans and Other Retiree Benefits (Tables)

12 Months Ended

Dec. 31, 2012

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

The following table presents a reconciliation of Level 3 plan assets measured at fair value for the year ended December 31:



	2012				2011
	United States Real Estate Fund		International Real Estate Fund		United States Real Estate Fund			International Real Estate Fund
Beginning balance as of January 1	$	64	$	18	$	55		$	16
Earned income, net of management expenses	6		—		9			—
Unrealized gain on investment	2		1		2			1
Purchases, sales, issuances and settlements, net	—		1		(2		)	1
Ending balance as of December 31	$	72	$	20	$	64		$	18

Schedule of Allocation of Plan Assets

The target asset allocation for the Company’s defined benefit plans are as follows:



	United States		International
Asset Category
Equity securities	52	%	43	%
Debt securities	40		42
Real estate and alternative investments	8		15
Total	100	%	100	%

At December 31, 2012 the allocation of the Company’s plan assets and the level of valuation input for each major asset category was as follows:



	Level of Valuation Input	Pension Plans
	Level of Valuation Input	United States		International		Other Retiree Benefits
Investments:
Cash & cash equivalents	Level 1	$	45	$	9	$	1
U.S. common stocks	Level 1	258		—		6
International common stocks	Level 1	93		—		2
Fixed income securities (a)	Level 2	142		—		—
Common/collective trust funds (b):	Level 2
Equity index funds		444		199		11
Emerging market equity index funds		65		12		2
Other common stock funds		40		65		1
Fixed income funds: U.S. or foreign government and agency securities		227		59		6
Fixed income funds: investment grade corporate bonds		26		72		1
Fixed income funds: high yield corporate bonds and other		185		1		5
Guaranteed investment contracts (c)	Level 2	2		49		—
Real estate (d)	Level 3	70		20		2
Total Investments at fair value		$	1,597	$	486	$	37

At December 31, 2011 the allocation of the Company’s plan assets and the level of valuation input for each major asset category was as follows:



	Level of Valuation Input	Pension Plans
	Level of Valuation Input	United States		International		Other Retiree Benefits
Investments:
Cash & cash equivalents	Level 1	$	67	$	12	$	2
U.S. common stocks	Level 1	209		—		5
International common stocks	Level 1	47		—		1
Fixed income securities (a)	Level 2	145		—		—
Common/collective trust funds (b):	Level 2
Equity index funds		405		158		10
Emerging market equity index funds		54		17		1
Other common stock funds		34		28		1
Fixed income funds: U.S. or foreign government and agency securities		268		82		7
Fixed income funds: investment grade corporate bonds		58		75		1
Fixed income funds: high yield corporate bonds and other		75		1		2
Guaranteed investment contracts (c)	Level 2	2		46		—
Real estate (d)	Level 3	62		18		2
Total Investments at fair value		$	1,426	$	437	$	32

_______


(a)	The fixed income securities are traded over the counter and a small portion of the securities lack daily pricing or liquidity and as such are classified as Level 2. As of December 31, 2012 and 2011, approximately 75% of the fixed income portfolio was invested in U.S. treasury or agency securities, with the remainder invested in corporate bonds.


(b)	Interests in common/collective trust funds are valued using the net asset value (NAV) per unit in each fund. The NAV is based on the value of the underlying investments owned by each trust, minus its liabilities, divided by the number of shares outstanding.


(c)	The guaranteed investment contracts (GICs) represent contracts with insurance companies measured at the cash surrender value of each contract. The Level 2 valuation reflects that the cash surrender value is based principally on a referenced pool of investment funds with active redemption.


(d)	Real estate is valued using the NAV per unit of funds that are invested in real property, and the real property is valued using independent market appraisals. Since the appraisals include unobservable inputs, the investments in each fund are classified as Level 3.

Schedule of Assumptions Used



	Pension Benefits						Other Retiree Benefits
	2012		2011	2012		2011	2012		2011
	United States			International
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount rate	4.14	%	4.90%	3.57	%	4.59%	4.32	%	5.26	%
Long-term rate of return on plan assets	7.30	%	7.75%	5.39	%	5.91%	7.30	%	7.75	%
Long-term rate of compensation increase	3.50	%	4.00%	2.80	%	2.87%	—	%	—	%
ESOP growth rate	—%		—%	—%		—%	10.00	%	10.00	%
Medical cost trend rate of increase	—%		—%	—%		—%	7.50	%	8.00	%

Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets

Plans with projected benefit obligations in excess of plan assets and plans with accumulated benefit obligations in excess of plan assets as of December 31 consist of the following:



	Years Ended December 31,
	2012		2011
Benefit Obligation Exceeds Fair Value of Plan Assets
Projected benefit obligation	$	3,112	$	2,770
Fair value of plan assets	2,080		1,809

Accumulated benefit obligation	2,855		2,525
Fair value of plan assets	2,044		1,773

Defined benefit plans disclosures



	Pension Benefits												Other Retiree Benefits
	2012			2011			2012			2011			2012			2011
	United States						International
Change in Benefit Obligations
Benefit obligations at beginning of year	$	2,025		$	1,952		$	760		$	736		$	776		$	762
Service cost	24			24			12			19			9			10
Interest cost	97			100			35			36			40			39
Participants’ contributions	1			1			3			4			—			—
Acquisitions/plan amendments	—			—			21			1			(27		)	—
Actuarial loss (gain)	200			126			103			21			119			(1		)
Foreign exchange impact	—			—			21			(10		)	1			(6		)
Termination benefits	—			—			—			—			—			—
Curtailments and settlements	—			—			(23		)	(14		)	—			1
Benefit payments	(128		)	(178		)	(45		)	(33		)	(40		)	(29		)
Other	8			—			1			—			(3		)	—
Benefit obligations at end of year	$	2,227		$	2,025		$	888		$	760		$	875		$	776
Change in Plan Assets
Fair value of plan assets at beginning of year	$	1,426		$	1,377		$	437		$	434		$	32		$	32
Actual return on plan assets	173			28			47			2			5			—
Company contributions	125			198			57			45			40			29
Participants’ contributions	1			1			3			4			—			—
Foreign exchange impact	—			—			13			(3		)	—			—
Settlements	—			—			(21		)	(12		)	—			—
Benefit payments	(128		)	(178		)	(45		)	(33		)	(40		)	(29		)
Other	—			—			(5		)	—			—			—
Fair value of plan assets at end of year	$	1,597		$	1,426		$	486		$	437		$	37		$	32
Funded Status
Benefit obligations at end of year	$	2,227		$	2,025		$	888		$	760		$	875		$	776
Fair value of plan assets at end of year	1,597			1,426			486			437			37			32
Net amount recognized	$	(630	)	$	(599	)	$	(402	)	$	(323	)	$	(838	)	$	(744	)
Amounts Recognized in Balance Sheet
Noncurrent assets	$	—		$	—		$	2		$	—		$	—		$	—
Current liabilities	(17		)	(15		)	(29		)	(29		)	(40		)	(40		)
Noncurrent liabilities	(613		)	(584		)	(375		)	(294		)	(798		)	(704		)
Net amount recognized	$	(630	)	$	(599	)	$	(402	)	$	(323	)	$	(838	)	$	(744	)
Amounts recognized in Accumulated other comprehensive income consist of
Actuarial loss	$	932		$	855		$	235		$	174		$	421		$	323
Transition/prior service cost	63			73			26			6			2			32
	$	995		$	928		$	261		$	180		$	423		$	355
Accumulated benefit obligation	$	2,093		$	1,892		$	798		$	688		$	—		$	—

Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates

A 1% change in the assumed medical cost trend rate would have the following approximate effect:



	One percentage point
	Increase		Decrease
Accumulated postretirement benefit obligation	$	112	$	(91	)
Annual expense	9		(7		)

Schedule of Net Benefit Costs

Summarized information regarding the net periodic benefit costs for the Company’s defined benefit and other retiree benefit plans is as follows:



	Pension Benefits																			Other Retiree Benefits
	2012			2011			2010				2012			2011			2010			2012			2011			2010
	United States										International
Components of Net Periodic Benefit Cost
Service cost	$	24		$	24		$	42			$	12		$	19		$	17		$	11		$	12		$	13
Interest cost	97			100			94				35			36			35			40			39			38
Annual ESOP allocation	—			—			—				—			—			—			(2		)	(2		)	(6		)
Expected return on plan assets	(112		)	(110		)	(99		)		(26		)	(27		)	(26		)	(3		)	(3		)	(2		)
Amortization of transition & prior service costs (credits)	9			9			5				2			3			3			3			2			1
Amortization of actuarial loss	62			46			52				9			9			9			18			16			19
Net periodic benefit cost	$	80		$	69		$	94			$	32		$	40		$	38		$	67		$	64		$	63
Other postretirement charges	—			—			23				9			3			1			1			1			8
Total pension cost	$	80		$	69		$	117			$	41		$	43		$	39		$	68		$	65		$	71
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount rate	4.90		%	5.30		%	5.75		%	⁽¹⁾	4.59		%	5.04		%	5.41		%	5.26		%	5.30		%	5.75		%	⁽¹⁾
Long-term rate of return on plan assets	7.75		%	8.00		%	8.00		%		5.91		%	6.23		%	6.58		%	7.75		%	8.00		%	8.00		%
Long-term rate of compensation increase	4.00		%	4.00		%	4.00		%		2.87		%	3.05		%	3.35		%	—		%	—		%	—		%
ESOP growth rate	—		%	—		%	—		%		—		%	—		%	—		%	10.00		%	10.00		%	10.00		%
Medical cost trend rate of increase	—		%	—		%	—		%		—		%	—		%	—		%	8.00		%	8.33		%	9.00		%

_______


⁽¹⁾	Effective with the plan amendments on September 1, 2010, the Company was required to remeasure the benefit obligations and plan assets of the affected plans, and a new discount rate of 4.75% was used to determine net periodic benefit cost through the end of 2011.

Schedule of Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized over Next Fiscal Year



	Pension Benefits		Other Retiree Benefits
Net actuarial loss	$	79	$	23
Net transition & prior service cost	11		—

Schedule of Expected Benefit Payments

Total benefit payments expected to be paid to participants from plan assets, or payments directly from the Company’s assets to participants in unfunded plans, are as follows:



	Pension Benefits
Years Ended December 31,	United States		International		Other Retiree Benefits		Total
2013	$	129	$	67	$	41	$	237
2014	128		50		42		220
2015	129		59		43		231
2016	129		54		44		227
2017	130		63		45		238
2018-2022	678		393		234		1,305

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2012

Components of income before income taxes

The components of income before income taxes are as follows for the three years ended December 31:



	2012		2011		2010
United States	$	1,155	$	1,098	$	1,252
International	2,719		2,691		2,178
Total Income before income taxes	$	3,874	$	3,789	$	3,430

Provision for Income Taxes

The provision for income taxes consists of the following for the three years ended December 31:



	2012		2011		2010
United States	$	395	$	360	$	427
International	848		875		690
Total Provision for income taxes	$	1,243	$	1,235	$	1,117

Schedule of Components of Income Tax Expense (Benefit)



	2012			2011			2010
Goodwill and intangible assets	$	(7	)	$	(1	)	$	(11	)
Property, plant and equipment	(13		)	(19		)	(29		)
Pension and other retiree benefits	(14		)	(47		)	4
Stock-based compensation	5			11			12
Tax loss and tax credit carryforwards	(39		)	(14		)	(28		)
Other, net	32			32			123
Total deferred tax provision	$	(36	)	$	(38	)	$	71

Effective tax rate reconciliation

The difference between the statutory U.S. federal income tax rate and the Company’s global effective tax rate as reflected in the Consolidated Statements of Income is as follows:



Percentage of Income before income taxes	2012		2011		2010
Tax at United States statutory rate	35.0	%	35.0	%	35.0	%
State income taxes, net of federal benefit	0.7		0.4		1.1
Earnings taxed at other than United States statutory rate	(2.6	)	(1.7	)	(4.6	)
Venezuela hyperinflationary transition charge	—		—		2.8
Other, net	(1.0	)	(1.1	)	(1.7	)
Effective tax rate	32.1	%	32.6	%	32.6	%

Components of deferred tax assets (liabilities)

The components of deferred tax assets (liabilities) are as follows at December 31:



	2012			2011
Deferred tax liabilities:
Goodwill and intangible assets	$	(476	)	$	(471	)
Property, plant and equipment	(365		)	(345		)
Other	(162		)	(104		)
	(1,003		)	(920		)
Deferred tax assets:
Pension and other retiree benefits	544			480
Tax loss and tax credit carryforwards	61			105
Accrued liabilities	208			176
Stock-based compensation	113			115
Other	151			111
	1,077			987
Net deferred income taxes	$	74		$	67



	2012			2011
Deferred taxes included within:
Assets:
Other current assets	$	275		$	204
Deferred income taxes	92			115
Liabilities:
Deferred income taxes	(293		)	(252		)
Net deferred income taxes	$	74		$	67

Unrecognized tax benefits activity

Unrecognized tax benefits activity for the years ended December 31, 2012, 2011 and 2010 is summarized below:



	2012			2011			2010
Unrecognized tax benefits:
Balance, January 1	$	176		$	171		$	187
Increases as a result of tax positions taken during the current year	34			76			38
Decreases of tax positions taken during prior years	(6		)	(46		)	(63		)
Increases of tax positions taken during prior years	10			10			16
Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations	(3		)	(30		)	(3		)
Effect of foreign currency rate movements	1			(5		)	(4		)
Balance, December 31	$	212		$	176		$	171

Tabular disclosure of tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities (i.e., uncertain tax positions) and other types of income tax contingencies, including: (1) the policy on classification of interest and penalties; (2) a tabular reconciliation of the total amounts of unrecognized tax benefits at the beginning and end of the period; the total amount(s) of: (3) unrecognized tax benefits that, if recognized, would affect the effective tax rate, and (4) interest and penalties recognized in each of the income statement and balance sheet; (5) for positions for which it is reasonably possible that the total amounts unrecognized will significantly change within 12 months of the reporting date the: (i) nature of the uncertainty, (ii) nature of the event that could occur that would cause the change, and (iii) an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made; and (6) a description of tax years that remain subject to examination by major tax jurisdictions.

Earnings Per Share (Tables)

12 Months Ended

Dec. 31, 2012

Schedule of Earnings Per Share, Basic and Diluted



	For the Year Ended 2012					For the Year Ended 2011					For the Year Ended 2010
	Income		Shares (millions)	Per Share		Income		Shares (millions)	Per Share		Income			Shares (millions)	Per Share
Net income attributable to Colgate-Palmolive Company	$	2,472				$	2,431				$	2,203
Preferred dividends	—					—					(34		)
Basic EPS	2,472		476.1	$	5.19	2,431		488.3	$	4.98	2,169			487.8	$	4.45
Stock options and restricted stock			4.0					3.7						3.3
Convertible preference stock	—		—			—		—			34			19.8
Diluted EPS	$	2,472	480.1	$	5.15	$	2,431	492.0	$	4.94	$	2,203		510.9	$	4.31

Segment Information (Tables)

12 Months Ended

Dec. 31, 2012

Schedule of Segment Reporting Information, by Segment



	2012		2011		2010
Net sales
Oral, Personal and Home Care
North America⁽¹⁾	$	3,096	$	2,995	$	3,005
Latin America	4,907		4,778		4,261
Europe/South Pacific	3,417		3,508		3,220
Greater Asia/Africa	3,505		3,281		2,998
Total Oral, Personal and Home Care	14,925		14,562		13,484
Pet Nutrition⁽²⁾	2,160		2,172		2,080
Total Net sales	$	17,085	$	16,734	$	15,564

_________


⁽¹⁾	Net sales in the U.S. for Oral, Personal and Home Care were $2,669, $2,567 and $2,591 in 2012, 2011 and 2010, respectively.


⁽²⁾	Net sales in the U.S. for Pet Nutrition were $1,052, $1,032 and $1,025 in 2012, 2011 and 2010, respectively.



	2012			2011			2010
Operating profit
Oral, Personal and Home Care
North America	$	834		$	791		$	884
Latin America	1,430			1,414			1,295
Europe/South Pacific	747			715			742
Greater Asia/Africa	886			807			767
Total Oral, Personal and Home Care	3,897			3,727			3,688
Pet Nutrition	589			560			559
Corporate	(597		)	(446		)	(758		)
Total Operating profit	$	3,889		$	3,841		$	3,489



	2012		2011		2010
Capital expenditures
Oral, Personal and Home Care
North America	$	43	$	54	$	57
Latin America	237		194		138
Europe/South Pacific	71		64		80
Greater Asia/Africa	104		119		111
Total Oral, Personal and Home Care	455		431		386
Pet Nutrition	37		32		81
Corporate	73		74		83
Total Capital expenditures	$	565	$	537	$	550



	2012		2011		2010
Depreciation and amortization
Oral, Personal and Home Care
North America	$	51	$	57	$	57
Latin America	90		91		84
Europe/South Pacific	85		82		67
Greater Asia/Africa	81		79		69
Total Oral, Personal and Home Care	307		309		277
Pet Nutrition	50		51		45
Corporate	68		61		54
Total Depreciation and amortization	$	425	$	421	$	376



Identifiable assets	2012		2011		2010
Oral, Personal and Home Care
North America	$	2,195	$	2,288	$	2,231
Latin America	4,250		3,636		3,092
Europe/South Pacific	3,649		3,555		2,775
Greater Asia/Africa	2,169		2,069		1,943
Total Oral, Personal and Home Care	12,263		11,548		10,041
Pet Nutrition	1,045		1,078		1,081
Corporate⁽³⁾	86		98		50
Total Identifiable assets⁽⁴⁾	$	13,394	$	12,724	$	11,172

____________


⁽³⁾	In 2012, Corporate identifiable assets primarily consist of derivative instruments (67%) and investments in equity securities (28%). In 2011, Corporate identifiable assets primarily consist of derivative instruments (73%) and investments in equity securities (22%). In 2010, Corporate identifiable assets primarily consist of derivative instruments (44%) and investments in equity securities (48%).


⁽⁴⁾	Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $8,066, $7,926 and $7,116 in 2012, 2011 and 2010, respectively.

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

Supplemental Income Statement Information (Tables)

12 Months Ended

Dec. 31, 2012

Other (income) expense, net



Other (income) expense, net	2012			2011			2010
Amortization of intangible assets	31			$	28		$	22
2012 Restructuring Program	81			—			—
Costs related to the sale of land in Mexico	—			13			—
Business realignment and other cost-saving initiatives	2			136			—
Gain on sales of non-core product lines	—			(207		)	(50		)
Charge for a French competition law matter	—			21			—
Sanex acquisition transaction costs	—			12			—
Venezuela hyperinflationary transition charge	—			—			271
Gain from remeasurement of Venezuelan balance sheet	—			—			(10		)
Termination benefits	—			—			86
Legal and environmental matters	7			11			(3		)
Asset impairments	—			—			5
Equity (income)	(7		)	(6		)	(5		)
Other, net	(1		)	(17		)	(15		)
Total Other (income) expense, net	$	113		$	(9	)	$	301

Interest expense, net



Interest expense, net	2012			2011			2010
Interest incurred	$	81		$	59		$	69
Interest capitalized	(1		)	(1		)	(4		)
Interest income	(65		)	(6		)	(6		)
Total Interest expense, net	$	15		$	52		$	59

Research and development and Advertising



	2012		2011		2010
Research and development	$	259	$	262	$	256
Advertising	$	1,792	$	1,734	$	1,656

Supplemental Balance Sheet Information (Tables)

12 Months Ended

Dec. 31, 2012

Schedule of Inventory, Current

Inventories by major class are as follows:



Inventories	2012		2011
Raw materials and supplies	$	362	$	319
Work-in-process	81		54
Finished goods	922		954
Total Inventories	$	1,365	$	1,327

Property, Plant and Equipment



Property, plant and equipment, net	2012			2011
Land	$	251		$	240
Buildings	1,439			1,342
Manufacturing machinery and equipment	4,987			4,673
Other equipment	1,144			1,069
	7,821			7,324
Accumulated depreciation	(3,979		)	(3,656		)
Total Property, plant and equipment, net	$	3,842		$	3,668

Other accruals



Other accruals	2012		2011
Accrued advertising and coupon redemption	$	646	$	555
Accrued payroll and employee benefits	345		293
Accrued taxes other than income taxes	48		35
Restructuring accrual	89		—
Pension and other retiree benefits	86		84
Accrued interest	26		22
Derivatives	10		6
Other	638		705
Total Other accruals	$	1,888	$	1,700

Other liabilities



Other liabilities	2012		2011
Pension and other retiree benefits	$	1,786	$	1,582
Other	263		203
Total Other liabilities	$	2,049	$	1,785

Supplemental Comprehensive Income Information (Tables)

12 Months Ended

Dec. 31, 2012

Other Comprehensive Income (Loss), Net of Tax [Abstract]

Schedule of Comprehensive Income (Loss)

Other Comprehensive Income components attributable to Colgate-Palmolive Company before tax and net of tax during the years ended December 31 were as follows:



	2012						2011						2010
	Pre-tax			Net of Tax			Pre-tax			Net of Tax			Pre-tax			Net of Tax

Cumulative translation adjustments	$	18		$	(20	)	$	(291	)	$	(298	)	$	166		$	162
Pension and other benefits:
Net actuarial loss and prior service costs arising during the period	(317		)	(207		)	(249		)	(163		)	(309		)	(196		)
Amortization of net actuarial loss, transition and prior service costs	101			62			85			55			89			53
Retirement Plan and other retiree benefit adjustments	(216		)	(145		)	(164		)	(108		)	(220		)	(143		)
Available-for-sale securities:
Unrealized gains (losses) on available- for-sale securities	28			18			60			46			(8		)	(8		)
Reclassification of (gains) losses into net earnings on available- for-sale securities	—			—			—			—			(36		)	(29		)
Gains (losses) on available-for sale securities	28			18			60			46			(44		)	(37		)
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	13			8			(10		)	(7		)	2			2
Reclassification of (gains) losses into net earnings on cash flow hedges	(11		)	(7		)	9			7			(4		)	(3		)
Gains (losses) on cash flow hedges	2			1			(1		)	—			(2		)	(1		)
Total Other comprehensive income	$	(168	)	$	(146	)	$	(396	)	$	(360	)	$	(100	)	$	(19	)

Quarterly Financial Data (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2012

Schedule of Quarterly Financial Information



	Total			First Quarter			Second Quarter			Third Quarter			Fourth Quarter
2012
Net sales	$	17,085		$	4,200		$	4,267		$	4,332		$	4,286
Gross profit	9,932		⁽¹⁾	2,437		⁽³⁾	2,461		⁽⁵⁾	2,529		⁽⁷⁾	2,505		⁽⁹⁾
Net income including noncontrolling interests	2,631		⁽²⁾	633		⁽⁴⁾	665		⁽⁶⁾	697		⁽⁸⁾	636		⁽¹⁰⁾
Net income attributable to Colgate-Palmolive Company	2,472		⁽²⁾	593		⁽⁴⁾	627		⁽⁶⁾	654		⁽⁸⁾	598		⁽¹⁰⁾
Earnings per common share:
Basic	5.19		⁽²⁾	1.24		⁽⁴⁾	1.31		⁽⁶⁾	1.38		⁽⁸⁾	1.27		⁽¹⁰⁾
Diluted	5.15		⁽²⁾	1.23		⁽⁴⁾	1.30		⁽⁶⁾	1.36		⁽⁸⁾	1.26		⁽¹⁰⁾

2011
Net sales	$	16,734		$	3,994		$	4,185		$	4,383		$	4,172
Gross profit	9,590		⁽¹¹⁾	2,331			2,404			2,462		⁽¹³⁾	2,393		⁽¹⁵⁾
Net income including noncontrolling interests	2,554		⁽¹²⁾	607			646			676		⁽¹⁴⁾	625		⁽¹⁶⁾
Net income attributable to Colgate-Palmolive Company	2,431		⁽¹²⁾	576			622			643		⁽¹⁴⁾	590		⁽¹⁶⁾
Earnings per common share:
Basic	4.98		⁽¹²⁾	1.17			1.27			1.32		⁽¹⁴⁾	1.22		⁽¹⁶⁾
Diluted	4.94		⁽¹²⁾	1.16			1.26			1.31		⁽¹⁴⁾	1.21		⁽¹⁶⁾

____________


Note:	Basic and diluted earnings per share are computed independently for each quarter presented. Accordingly, the sum of the quarterly earnings per common share may not agree with the calculated full year earnings per common share.


⁽¹⁾	Gross profit for the full year of 2012 includes $2 of charges related to the 2012 Restructuring Program, $24 of costs related to the sale of land in Mexico and $5 of costs associated with the business realignment and other cost-saving initiatives.


⁽²⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2012 include $70 of aftertax charges related to the 2012 Restructuring Program, $18 of aftertax costs related to the sale of land in Mexico and $14 of aftertax costs associated with the business realignment and other cost-saving initiatives.


⁽³⁾	Gross profit for the first quarter of 2012 includes $7 of costs related to the sale of land in Mexico and $2 of costs associated with the business realignment and other cost-saving initiatives.


⁽⁴⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the first quarter of 2012 include $5 of aftertax costs related to the sale of land in Mexico and $3 of aftertax costs associated with the business realignment and other cost-saving initiatives.


⁽⁵⁾	Gross profit for the second quarter of 2012 includes $6 of costs related to the sale of land in Mexico and $2 of costs associated with the business realignment and other cost-saving initiatives.


⁽⁶⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the second quarter of 2012 include $5 of aftertax costs related to the sale of land in Mexico and $9 of aftertax costs associated with the business realignment and other cost-saving initiatives.


⁽⁷⁾	Gross profit for the third quarter of 2012 includes $7 of costs related to the sale of land in Mexico and $1 of costs associated with the business realignment and other cost-saving initiatives.


⁽⁸⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the third quarter of 2012 include $5 of aftertax costs related to the sale of land in Mexico and $2 of aftertax costs associated with the business realignment and other cost-saving initiatives.


⁽⁹⁾	Gross profit for the fourth quarter of 2012 includes $2 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.


⁽¹⁰⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the fourth quarter of 2012 include $70 of aftertax charges related to the 2012 Restructuring Program and $3 of aftertax costs related to the sale of land in Mexico.


⁽¹¹⁾	Gross profit for the full year of 2011 includes $44 of costs associated with the business realignment and other cost-saving initiatives.

⁽¹²⁾


⁽¹³⁾	Gross profit for the third quarter of 2011 includes $28 of costs associated with the business realignment and other cost-saving initiatives.

⁽¹⁴⁾


⁽¹⁵⁾	Gross profit for the fourth quarter of 2011 includes $16 of costs associated with the business realignment and other cost-saving initiatives.

⁽¹⁶⁾

Schedule II - Valuation and Qualifying Accounts (Tables)

12 Months Ended

Dec. 31, 2012

Schedule II - Valuation and Qualifying Accounts [Tables] [Abstract]

Summary of Valuation Allowance [Table Text Block]



Column A	Column B		Column C				Column D			Column E
			Additions
	Balance at Beginning of Period		Charged to Costs and Expenses		Other		Deductions			Balance at End of Period
Year Ended December 31, 2012
Allowance for doubtful accounts and estimated returns	$	49	$	18	$	—	$	6		$	61
Valuation allowance for deferred tax assets	$	1	$	—	$	—	$	—		$	1

Year Ended December 31, 2011
Allowance for doubtful accounts and estimated returns	$	53	$	6	$	—	$	10		$	49
Valuation allowance for deferred tax assets	$	1	$	—	$	—	$	—		$	1

Year Ended December 31, 2010
Allowance for doubtful accounts and estimated returns	$	52	$	1	$	—	$	—		$	53
Valuation allowance for deferred tax assets	$	2	$	—	$	—	$	1	⁽¹⁾	$	1

Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.

Nature of Operations (Details) - businesssegments	12 Months Ended
Nature of Operations (Details) - businesssegments	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Notes to Financial Statements [Abstract]
Number of business segments (in number of segments)	2
Entity-Wide Information, Revenue from External Customer [Line Items]
Percentage of worldwide sales (in hundredths)	100.00%	100.00%	100.00%
Oral Care [Member]
Entity-Wide Information, Revenue from External Customer [Line Items]
Percentage of worldwide sales (in hundredths)	44.00%	43.00%	43.00%
Personal Care [Member]
Entity-Wide Information, Revenue from External Customer [Line Items]
Percentage of worldwide sales (in hundredths)	22.00%	22.00%	22.00%
Home Care [Member]
Entity-Wide Information, Revenue from External Customer [Line Items]
Percentage of worldwide sales (in hundredths)	21.00%	22.00%	22.00%
Pet Nutrition [Member]
Entity-Wide Information, Revenue from External Customer [Line Items]
Percentage of worldwide sales (in hundredths)	13.00%	13.00%	13.00%

Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Principles of Consolidation [Abstract]
Investments accounted for using the equity method, minimum interest (in hundredths)	20.00%
Investments accounted for using the equity method, maximum interest (in hundredths)	50.00%
Equity method investments included in Other assets	$ 25	$ 20
Investments accounted for using the cost method, maximum interest (in hundredths)	20.00%
Shipping and Handling Costs [Abstract]
Shipping and handling costs classified as Selling, general and administrative expenses	$ 1,262	$ 1,250	$ 1,142
Inventories [Abstract]
Approximate percentage of inventories determined using the first-in, first-out (FIFO) method (in hundredths)	80.00%
Minimum [Member] \| Machinery and equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life (in years)	3 years
Maximum [Member] \| Machinery and equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life (in years)	15 years
Maximum [Member] \| Buildings [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life (in years)	40 years

Summary of Significant Accounting Policies (Details 1) - Trademarks, local brands, and non-compete agreements [Member]	12 Months Ended
	Dec. 31, 2012
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of finite-lived intangible assets (in years)	5 years
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of finite-lived intangible assets (in years)	40 years

Acquisitions and Divestitures (Details) € in Millions, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2012 USD ($)	Sep. 30, 2012 USD ($)	Jun. 30, 2012 USD ($)	Mar. 31, 2012 USD ($)	Dec. 31, 2011 USD ($)	Sep. 30, 2011 USD ($)	Jun. 30, 2011	Dec. 31, 2010 USD ($)	Dec. 31, 2012 USD ($)	Dec. 31, 2011 USD ($)	Dec. 31, 2010 USD ($)	Jun. 20, 2011 EUR (€)	Jun. 20, 2011 USD ($)
Sale of Land in Mexico [Abstract]
First Installment received from the sale of land in Mexico						$ 24
Second Installment received from the sale of land in Mexico		$ 36
Pretax costs related to sale of land										$ 13
Aftertax costs related to sale of land										9
Sale of brands [Abstract]
Proceeds from sales of assets						215
Gain before tax on sales of non-core product lines						207		$ 50	$ 0	207	$ 50
Gain after tax on sales of non core products						135		$ 30		135
Recognized amounts of assets acquired and liabilities assumed [Abstract]
Transaction costs									0	12	0
Sanex Personal Care Business [Member]
Business Acquisition [Line Items]
Aggregate purchase price												€ 676	$ 966
Recognized amounts of assets acquired and liabilities assumed [Abstract]
Inventories													26
Property, plant and equipment, net													3
Other intangible assets, net													596
Goodwill, net													411
Accrued income taxes													(48)
Deferred Tax Liabilities, Noncurrent													(18)
Long-term other liabilities													(4)
Fair value of net assets acquired													966
Sanex Personal Care Business [Member] \| Customer Relationships [Member]
Recognized amounts of assets acquired and liabilities assumed [Abstract]
Acquired finite-lived intangible assets													193
Sanex Personal Care Business [Member] \| Trademarks [Member]
Recognized amounts of assets acquired and liabilities assumed [Abstract]
Acquired indefinite-lived intangible assets													$ 403
Minimum [Member] \| Sanex Personal Care Business [Member] \| Customer Relationships [Member]
Recognized amounts of assets acquired and liabilities assumed [Abstract]
Estimated useful life of finite-lived intangible assets (in years)							15 years
Maximum [Member] \| Sanex Personal Care Business [Member] \| Customer Relationships [Member]
Recognized amounts of assets acquired and liabilities assumed [Abstract]
Estimated useful life of finite-lived intangible assets (in years)							18 years
MEXICO
Sale of Land in Mexico [Abstract]
Pretax costs related to sale of land	$ 4	7	$ 6	$ 7
Aftertax costs related to sale of land	$ 3	$ 5	$ 5	$ 5	$ 4	$ 5			18	9
Cost of Sales [Member]
Sale of Land in Mexico [Abstract]
Pretax costs related to sale of land									24
Other (Income) Expense, Net [Member]
Sale of Land in Mexico [Abstract]
Pretax costs related to sale of land									$ 0	$ 13	$ 0

Acquisitions and Divestitures (Details 1)	Jun. 20, 2011
Europe/South Pacific [Member]
Indefinite-lived Intangible Assets by Segment [Line Items]
Allocation of goodwill (in hundredths)	90.00%
Greater Asia/Africa [Member]
Indefinite-lived Intangible Assets by Segment [Line Items]
Allocation of goodwill (in hundredths)	10.00%

Restructuring and Related Implementation Charges (Details) - Two Thousand Twelve Restructuring Program [Member] $ in Millions	12 Months Ended
	Dec. 31, 2012 USD ($) employees
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	$ 89
Duration Of Restructuring Program	4 years
Percent of Restructuring Charges Resulting In Cash Expenditure	75.00%
Percentage Reduction Of Global Employee Workforce	6.00%
Current Number Of Employees \| employees	38,000
One-time Termination Benefits [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	$ 78
Estimated Percent Of Total Cumulative Pretax Charges Of Implementing 2012 Restructuring Program	50.00%
Incremental Depreciation And Asset Impairment [Member]
Restructuring Cost and Reserve [Line Items]
Estimated Percent Of Total Cumulative Pretax Charges Of Implementing 2012 Restructuring Program	15.00%
Charges Resulting Directly From Exit Activities [Member]
Restructuring Cost and Reserve [Line Items]
Estimated Percent Of Total Cumulative Pretax Charges Of Implementing 2012 Restructuring Program	20.00%
Contract Termination [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	$ 3
Implementation Of New Strategies [Member]
Restructuring Cost and Reserve [Line Items]
Estimated Percent Of Total Cumulative Pretax Charges Of Implementing 2012 Restructuring Program	15.00%
Third party Incremental Cost [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	$ 8
Pet Nutrition [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment	15.00%
Percent Of Total Restructuring Charges Related To Segment	3.00%
Corporate [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment	35.00%
Percent Of Total Restructuring Charges Related To Segment	38.00%
North America [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment	15.00%
Percent Of Total Restructuring Charges Related To Segment	2.00%
Europe/South Pacific [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment	20.00%
Percent Of Total Restructuring Charges Related To Segment	55.00%
Latin America [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment	5.00%
Greater Asia/Africa [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment	10.00%
Percent Of Total Restructuring Charges Related To Segment	2.00%
Expected Completion Date 2016 [Member] \| Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Program Expected Cost Before Tax	$ 1,100
Restructuring Program Expected Cost After Tax	775
Expected Completion Date 2016 [Member] \| Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Program Expected Cost Before Tax	1,250
Restructuring Program Expected Cost After Tax	875
Expected Completion Date December 2013 [Member] \| Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Program Expected Cost Before Tax	260
Restructuring Program Expected Cost After Tax	185
Expected Completion Date December 2013 [Member] \| Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Program Expected Cost Before Tax	310
Restructuring Program Expected Cost After Tax	$ 220

Restructuring and Related Implementation Charges (Details 1) - Two Thousand Twelve Restructuring Program [Member] - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost		$ 89
Restructuring And Related Cost, Incurred Cost, After Tax	$ 70	70
Cost of Sales [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	$ 2	2
Selling, General and Administrative Expenses [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost		6
Other (Income) Expense, Net [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost		$ 81	$ 0	$ 0

Restructuring and Related Implementation Charges (Details 2) - Two Thousand Twelve Restructuring Program [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	$ 89
Cash payments	(5)
Charges against assets	0
Other	0
Foreign exchange	5
Balance at December 31, 2012	89	$ 0
One-time Termination Benefits [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	78
Cash payments	(1)
Charges against assets	0
Other	0
Foreign exchange	7
Balance at December 31, 2012	84
Incremental Depreciation [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	0
Cash payments	0
Charges against assets	0
Other	0
Foreign exchange	0
Balance at December 31, 2012	0
Asset Impairment [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	0
Cash payments	0
Charges against assets	0
Other	0
Foreign exchange	0
Balance at December 31, 2012	0
Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	11
Cash payments	(4)
Charges against assets	0
Other	0
Foreign exchange	(2)
Balance at December 31, 2012	$ 5

Goodwill and Other Intangible Assets (Details) - USD ($) $ in Millions	Dec. 31, 2012	Dec. 31, 2011
Goodwill [Line Items]
Goodwill	$ 2,500	$ 2,494
Oral, Personal and Home Care [Member]
Goodwill [Line Items]
Goodwill	2,485	2,479
Oral, Personal and Home Care [Member] \| North America [Member]
Goodwill [Line Items]
Goodwill	374	370
Oral, Personal and Home Care [Member] \| Latin America [Member]
Goodwill [Line Items]
Goodwill	406	434
Oral, Personal and Home Care [Member] \| Europe/South Pacific [Member]
Goodwill [Line Items]
Goodwill	1,478	1,450
Oral, Personal and Home Care [Member] \| Greater Asia/Africa [Member]
Goodwill [Line Items]
Goodwill	227	225
Pet Nutrition [Member]
Goodwill [Line Items]
Goodwill	$ 15	$ 15

Carrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 45
-Subparagraph e
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 43
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 72
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 45
-Subparagraph e
-Clause 1
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-Subparagraph l
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 34
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Goodwill and Other Intangible Assets (Details 1) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Jun. 20, 2011
Finite and indefinite-lived intangible assets [Line Items]
Finite & Indefinite Life Intangibles, Gross	$ 1,787	$ 1,758
Finite-Lived Intangible Assets, Accumulated Amortization	(288)	(254)
Intangible Assets, Net (Excluding Goodwill)	1,499	1,504
Amortization of Intangible Assets	31	28	$ 22
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Future amortization expense - 2013	29
Future amortization expense - 2014	29
Future amortization expense - 2015	29
Future amortization expense - 2016	29
Future amortization expense - 2017	29
Trademarks [Member]
Finite and indefinite-lived intangible assets [Line Items]
Finite-Lived Intangible Assets, Gross	548	536
Finite-Lived Intangible Assets, Accumulated Amortization	(254)	(236)
Intangible Assets, Net (Excluding Goodwill)	294	300
Other finite-life intangible assets [Member]
Finite and indefinite-lived intangible assets [Line Items]
Finite-Lived Intangible Assets, Gross	212	205
Finite-Lived Intangible Assets, Accumulated Amortization	(34)	(18)
Intangible Assets, Net (Excluding Goodwill)	178	187
Indefinite-life intangible assets [Member]
Finite and indefinite-lived intangible assets [Line Items]
Indefinite-Lived Intangible Assets (Excluding Goodwill)	1,027	1,017
Finite-Lived Intangible Assets, Accumulated Amortization	0	0
Intangible Assets, Net (Excluding Goodwill)	$ 1,027	$ 1,017
Trademarks [Member] \| Sanex Personal Care Business [Member]
Finite and indefinite-lived intangible assets [Line Items]
Acquired Indefinite-lived Intangible Asset, Amount				$ 403
Customer Relationships [Member] \| Sanex Personal Care Business [Member]
Finite and indefinite-lived intangible assets [Line Items]
Acquired Finite-lived Intangible Asset, Amount				$ 193

Long-Term Debt and Credit Facilities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Debt Instrument [Line Items]
Total debt	$ 5,176	$ 4,776
Less: Current portion of long-term debt	(250)	(346)
Long-term Debt, Excluding Current Maturities	4,926	4,430
Short-term Bank Loans and Notes Payable	$ 54	$ 34
Weighted-average interest rate on short term borrowings (in hundredths)	1.00%	0.90%
Scheduled maturities of long-term debt [Abstract]
2012	$ 250
2013	887
2014	494
2015	254
2016	678
Thereafter	$ 2,170
Notes Payable, Other Payables [Member]
Debt Instrument [Line Items]
Weighted average interest rate (in hundredths)	2.10%
Maturity date range, start	Dec. 31, 2013
Maturity date range, end	Dec. 31, 2078
Total debt	$ 4,733	$ 4,089
Notes Payable to Banks [Member]
Debt Instrument [Line Items]
Weighted average interest rate (in hundredths)	0.00%
Total debt	$ 0	16
Commercial Paper [Member]
Debt Instrument [Line Items]
Weighted average interest rate (in hundredths)	0.10%
Maturity date	2013
Total debt	$ 443	$ 671

Long-Term Debt and Credit Facilities (Details 1) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Three Year Notes at Point Six Percent [Member]
Schedule of U.S. dollar-denominated notes [Line Items]
Face amount		$ 300
Term of notes (in years)		three-year
Fixed Interest rate (in hundredths)		0.60%
Five Year Notes at 1 Point 3 Percent [Member]
Schedule of U.S. dollar-denominated notes [Line Items]
Face amount		$ 400
Term of notes (in years)		five-year
Fixed Interest rate (in hundredths)		1.30%
Ten Year Notes at 2 Point 45 Percent [Member]
Schedule of U.S. dollar-denominated notes [Line Items]
Face amount		$ 300
Term of notes (in years)		ten-year
Fixed Interest rate (in hundredths)		2.45%
Three Year Notes at 1 Point 25 Percent [Member]
Schedule of U.S. dollar-denominated notes [Line Items]
Face amount		$ 250
Term of notes (in years)		three-year
Fixed Interest rate (in hundredths)		1.25%
Six Year Notes at 2 Point 625 Percent [Member]
Schedule of U.S. dollar-denominated notes [Line Items]
Face amount		$ 250
Term of notes (in years)		six-year
Fixed Interest rate (in hundredths)		2.625%
Ten Year Notes at 2 Point 3 Percent [Member]
Schedule of U.S. dollar-denominated notes [Line Items]
Face amount	$ 500
Term of notes (in years)	ten-year
Fixed Interest rate (in hundredths)	2.30%
Ten Year Notes at 1 Point 95 Percent [Member]
Schedule of U.S. dollar-denominated notes [Line Items]
Face amount	$ 500
Term of notes (in years)	ten-year
Fixed Interest rate (in hundredths)	1.95%

Long-Term Debt and Credit Facilities (Details 2) $ in Millions	Dec. 31, 2012 USD ($)
Domestic Revolving Credit Facility 1850 Million Capacity [Member]
Line of credit facility [Line Items]
Maximum borrowing capacity	$ 1,850
Line of Credit [Member]
Line of credit facility [Line Items]
Unused borrowing capacity	2,547
Domestic Revolving Credit Facility 145 Million Capacity [Member]
Line of credit facility [Line Items]
Maximum borrowing capacity	$ 145

Financial Instruments and Fair Value Measurements (Details 1) - USD ($) $ in Millions	Dec. 31, 2012	Dec. 31, 2011
Derivative Instruments [Abstract]
Total asset derivative instruments	$ 65	$ 81
Derivative Asset Designated as Hedging Instrument	65	78
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	0	3
Total liability derivative instruments	11	9
Derivative Liability Designated as Hedging Instrument	10	9
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	1	0
Financial Instruments Recorded In Other Current Assets [Member]
Financial Instruments [Abstract]
Marketable securities	116	72
Financial Instruments Recorded In Other Assets [Member]
Financial Instruments [Abstract]
Venezuelan bonds, long-term	618	236
Interest Rate Swap Contracts [Member] \| Other Assets [Member]
Derivative Instruments [Abstract]
Derivative Asset Designated as Hedging Instrument	41	40
Interest Rate Swap Contracts [Member] \| Other Current Assets [Member]
Derivative Instruments [Abstract]
Derivative Asset Designated as Hedging Instrument	3	2
Interest Rate Swap Contracts [Member] \| Other Liabilities [Member]
Derivative Instruments [Abstract]
Derivative Liability Designated as Hedging Instrument	0	2
Interest Rate Swap Contracts [Member] \| Other Accruals [Member]
Derivative Instruments [Abstract]
Derivative Liability Designated as Hedging Instrument	0	0
Foreign Currency Contracts [Member] \| Other Assets [Member]
Derivative Instruments [Abstract]
Derivative Asset Designated as Hedging Instrument	13	28
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	0	3
Foreign Currency Contracts [Member] \| Other Current Assets [Member]
Derivative Instruments [Abstract]
Derivative Asset Designated as Hedging Instrument	7	8
Foreign Currency Contracts [Member] \| Other Liabilities [Member]
Derivative Instruments [Abstract]
Derivative Liability Designated as Hedging Instrument	0	0
Foreign Currency Contracts [Member] \| Other Accruals [Member]
Derivative Instruments [Abstract]
Derivative Liability Designated as Hedging Instrument	10	6
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	1	0
Commodity Contracts [Member] \| Other Current Assets [Member]
Derivative Instruments [Abstract]
Derivative Asset Designated as Hedging Instrument	1	0
Commodity Contracts [Member] \| Other Accruals [Member]
Derivative Instruments [Abstract]
Derivative Liability Designated as Hedging Instrument	0	1
Fair Value [Member]
Financial Instruments [Abstract]
Total other financial instruments	$ 734	$ 308

Financial Instruments and Fair Value Measurements (Details 2) - USD ($) $ in Millions	Dec. 31, 2012	Dec. 31, 2011
Debt Instrument [Line Items]
Long-term Debt	$ 5,176	$ 4,776
Carrying Value [Member]
Debt Instrument [Line Items]
Long-term Debt	5,176	4,776
Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Debt Instrument, Fair Value Disclosure	$ 5,484	$ 5,121

Financial Instruments and Fair Value Measurements (Details 3) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Jun. 30, 2011	Dec. 31, 2012	Dec. 31, 2011
Activity related to fair value hedges [Abstract]
Notional Value		$ 2,455	$ 2,338
Gain (loss) on derivative		15	30
Gain (loss) on hedged items		(15)	(30)
Activity related to cash flow hedges [Abstract]
Notional Value		421	435
Gain (loss) recognized in OCI		13	(10)
Gain (loss) reclassified into Cost of sales		11	(9)
Activity related to net investment hedges [Abstract]
Notional Value		905	679
Gain (loss) on instruments		(19)	9
Gain (loss) on hedged items		16	(9)
Interest Rate Swap Contracts [Member]
Activity related to fair value hedges [Abstract]
Notional Value		1,338	1,668
Gain (loss) on derivative		6	25
Gain (loss) on hedged items		(6)	(25)
Foreign Currency Contracts [Member]
Activity related to fair value hedges [Abstract]
Notional Value		1,117	670
Gain (loss) on derivative		9	5
Gain (loss) on hedged items		(9)	(5)
Activity related to cash flow hedges [Abstract]
Notional Value		398	403
Gain (loss) recognized in OCI		4	(9)
Gain (loss) reclassified into Cost of sales		4	(13)
Activity related to net investment hedges [Abstract]
Notional Value		522	485
Gain (loss) on instruments		(11)	8
Gain (loss) on hedged items		8	(8)
Commodity Contracts [Member]
Activity related to cash flow hedges [Abstract]
Notional Value		23	32
Gain (loss) recognized in OCI		9	(1)
Gain (loss) reclassified into Cost of sales		7	4
Foreign Currency Denominated Debt [Member]
Activity related to net investment hedges [Abstract]
Notional Value		383	194
Gain (loss) on instruments		(8)	1
Gain (loss) on hedged items		8	(1)
Cross-Currency Swap (Member)
Activity related to derivatives not designated as hedging instruments [Abstract]
Notional Value		96	96
Gain (loss) on instrument		(4)	(1)
Gain (loss) on hedged item		$ 4	$ 1
Net realized gain (loss) of a cross-currency swap	$ (6)

Financial Instruments and Fair Value Measurements (Details 4) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Mar. 31, 2011
Schedule of Available-for-sale Securities [Line Items]
Fair Value of U.S. dollar-linked, devaluation-protected bonds	$ 255
Fair Value of fixed interest rate bonds	387
Unrealized gain on investment			$ (62)
Bonds Issued By Venezuelan Government [Member]
Venezuelan Investments [Roll Forward]
Beginning balance	236	$ 96
Unrealized gain (loss) on investment	28	61
Purchases and sales during the period	378	79
Ending balance	$ 642	$ 236

This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale.

Defined Benefit Plan Disclosure [Line Items]

Capital Stock and Stock-Based Compensation Plans (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 1989	Dec. 29, 2010
Preference Stock [Abstract]
Shares authorized (in shares)	50,000,000
Series B Convertible Preference stock (in shares)				6,315,149
Common Stock Shares Converted From One Share Of Preferred Stock				8
Redemption price (in dollars per share)				$ 65
Minimum cumulative dividend rate for Convertible Preference stock (in dollars per share)				$ 2.44
Preference stock retired (in shares)					2,405,192
Common stock converted (in shares)					19,241,536
Common stock outstanding and issued to Employee Stock Ownership Plan (in shares)	15,610,648	17,102,005
Stock Repurchases [Abstract]
Repurchased stock	$ 1,943	$ 1,806	$ 2,020
Summary of common stock activity [Roll Forward]
Common Stock Balance, January 1 (in shares)	480,018,075	494,850,467	494,165,017
Common stock acquired (in shares)	(19,365,301)	(21,320,936)	(25,401,785)
Shares issued for stock options (in shares)	6,108,615	5,758,879	4,233,775
Shares issued for restricted stock and other (in shares)	1,102,949	729,665	993,132
Preference stock conversion (in shares)			20,860,328
Common Stock Balance, December 31 (in shares)	467,864,338	480,018,075	494,850,467
Summary Of Treasury Stock Activity [Roll Forward]
Treasury Stock Balance, January 1 (in shares)	252,835,105	238,002,713	238,688,163
Common stock acquired (in shares)	19,365,301	21,320,936	25,401,785
Shares issued for stock options (in shares)	(6,108,615)	(5,758,879)	(4,233,775)
Shares issued for restricted stock and other (in shares)	(1,102,949)	(729,665)	(993,132)
Preference stock conversion (in shares)			(20,860,328)
Treasury Stock Balance, December 31 (in shares)	264,988,842	252,835,105	238,002,713
Stock-based compensation [Abstract]
Allocated Share-based Compensation Expense	$ 120	$ 122	$ 121
Total income tax benefit	$ 37	$ 40	$ 40
Fair Value Assumptions [Abstract]
Weighted-average estimated fair value of stock options granted (in dollars per share)	$ 13.46	$ 11.93	$ 11.00
Expected term (in years)	4 years 6 months	4 years 6 months	4 years 6 months
Expected Volatility Rate (in hundredths)	20.80%	21.30%	22.50%
Risk-Free Rate (in hundredths)	0.60%	0.80%	1.30%
Expected Dividend Yield (in hundredths)	2.40%	2.60%	2.80%
Summary of restricted stock award activity [Roll Forward]
Restricted stock awards - beginning balance (in shares)	3,037,000
Granted (in shares)	734,000
Vested (in shares)	(1,062,000)
Forfeited (in shares)	(75,000)
Restricted stock awards - ending balance (in shares)	2,634,000	3,037,000
Additional disclosures pertaining to restricted stock awards [Abstract]
Weighted average grant date fair value of restricted stock awards - beginning of period (in dollars per share)	$ 76
Weighted average grant date fair value of restricted stock awards - shares granted (in dollars per share)	100
Weighted average grant date fair value of restricted stock awards - shares vested (in dollars per share)	66
Weighted average grant date fair value of restricted stock awards - shares forfeited (in dollars per share)	82
Weighted average grant date fair value of restricted stock awards - end of period (in dollars per share)	$ 87	$ 76
Summary of stock option plan activity [Roll Forward]
Options - beginning balance (in shares)	22,294,000
Granted (in shares)	5,261,000
Shares issued for stock options (in shares)	(6,217,000)
Forfeited or expired (in shares)	(167,000)
Options - ending balance (in shares)	21,171,000	22,294,000
Options exercisable (in shares)	11,635,000
Additional disclosures pertaining to stock options [Abstract]
Weighted average exercise price of options - beginning of period (in dollars per share)	$ 76
Weighted average exercise price of options - shares granted (in dollars per share)	104
Weighted average exercise price of options - shares exercised (in dollars per share)	68
Weighted average exercise price of options - shares forfeited or expired (in dollars per share)	85
Weighted average exercise price of options - end of period (in dollars per share)	85	$ 76
Weighted average exercise price of options exercisable - end of period (in dollars per share)	$ 77
Weighted average remaining contractual life, options outstanding (in years)	4 years
Weighted average remaining contractual life, options exercisable (in years)	3 years
Value of unexercised in-the-money options, options outstanding	$ 406
Value of unexercised in-the-money options, options exercisable	322
Stock-based compensation, additional disclosures [Abstract]
Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options	60	$ 32	$ 31
Proceeds from Stock Options Exercised	$ 409	332	211
Vesting period (in years)	3 years
Contractual term (in years)	6 years
Program 2011 [Member]
Stock Repurchases [Abstract]
Treasury stock repurchase authorization (in shares)	50,000,000
Incentive Stock Plans [Member]
Additional disclosures pertaining to restricted stock awards [Abstract]
Number of shares available for grant (in shares)	8,650,000
Unrecognized compensation expense	$ 70
Unrecognized compensation expense, weighted-average period of recognition in years	2 years 3 months 18 days
Total fair value of shares vested	$ 63	50	69
Stock Option Plans [Member]
Additional disclosures pertaining to restricted stock awards [Abstract]
Number of shares available for grant (in shares)	3,999,000
Unrecognized compensation expense	$ 48
Unrecognized compensation expense, weighted-average period of recognition in years	1 year 7 months 6 days
Stock-based compensation, additional disclosures [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value	$ 210	162	133
Treasury Stock [Member]
Preference Stock [Abstract]
Treasury Stock, Value, Acquired, Cost Method	$ 1,943	$ 1,806	$ 2,020

Employee Stock Ownership Plan (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 1989	Dec. 29, 2010
Notes to Financial Statements [Abstract]
Long-term notes issued by ESOP				$ 410
Average interest rate on ESOP notes (in hundredths)				8.70%
Preference stock purchased from the proceeds of the notes (in shares)				6,315,149
Number of shares of common stock that each share of preference stock can be converted (in shares)				8
Redemption price (in dollars per share)				$ 65
Preference stock retired (in shares)					2,405,192
Minimum cumulative dividend rate for Convertible Preference stock (in dollars per share)				$ 2.44
Common stock converted (in shares)					19,241,536
Common Stock Outstanding And Issued To Employee Stock Ownership Plan	15,610,648	17,102,005
Advances from the Company	$ 41
Common shares released and allocated to participant accounts (in shares)	9,635,421
Common shares available for future allocation to participant accounts (in shares)	5,975,227
Annual ESOP expense	$ 0	$ 0	$ 6
Interest incurred on ESOP notes	0	0	0
Dividends paid by the Company on shares held by the ESOP	40	42	41
Company contributions to the ESOP	$ 0	$ 0	$ 6

Retirement Plans and Other Retiree Benefits (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Percentage Of Fixed Income Portfolio Invested In Us Treasury Or Agency Securities

75.00%

United States Pension Benefits [Member]

Defined Benefit Plan, Assets, Target Allocations [Abstract]

Real estate and alternative investments (in hundredths)

8.00%

Total (in hundredths)

100.00%

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

Percentage of fixed income portfolio invested in U.S. treasury or agency securities (in hundredths)

$ 1,597

$ 1,426

$ 1,377

$ 4

$ 3

Defined Benefit Plan Percentage Of Equity Securities Invested In Employer Securities

11.00%

United States Pension Benefits [Member] | Equity Securities [Member]

Defined Benefit Plan, Assets, Target Allocations [Abstract]

United States Pension Benefits [Member] | Cash & cash equivalents [Member] | Level 1 [Member]

52.00%

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

United States Pension Benefits [Member] | U.S. common stocks [Member] | Level 1 [Member]

$ 45

$ 67

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

United States Pension Benefits [Member] | International common stocks [Member] | Level 1 [Member]

258

209

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

United States Pension Benefits [Member] | Fixed income securities [Member]

$ 93

Defined Benefit Plan, Assets, Target Allocations [Abstract]

United States Pension Benefits [Member] | Fixed income securities [Member] | Level 2 [Member]

40.00%

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

United States Pension Benefits [Member] | Equity index funds [Member] | Level 2 [Member]

^[1]

$ 142

145

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

United States Pension Benefits [Member] | Emerging market equity index funds [Member] | Level 2 [Member]

^[2]

444

405

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

United States Pension Benefits [Member] | Other common stock funds [Member] | Level 2 [Member]

^[2]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

United States Pension Benefits [Member] | Fixed income funds: U.S. or foreign government and agency securities [Member] | Level 2 [Member]

^[2]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

United States Pension Benefits [Member] | Fixed income funds: investment grade corporate bonds [Member] | Level 2 [Member]

^[2]

227

268

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

United States Pension Benefits [Member] | Fixed income funds: high yield corporate bonds and other [Member] | Level 2 [Member]

^[2]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

United States Pension Benefits [Member] | Guaranteed investment contracts [Member] | Level 2 [Member]

^[2]

185

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

United States Pension Benefits [Member] | Real estate [Member] | Level 3 [Member]

^[3]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

International Pension Benefits [Member]

^[4]

$ 70

Defined Benefit Plan, Assets, Target Allocations [Abstract]

Real estate and alternative investments (in hundredths)

15.00%

Total (in hundredths)

100.00%

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

International Pension Benefits [Member] | Equity Securities [Member]

$ 486

437

434

Defined Benefit Plan, Assets, Target Allocations [Abstract]

International Pension Benefits [Member] | Cash & cash equivalents [Member] | Level 1 [Member]

43.00%

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

International Pension Benefits [Member] | U.S. common stocks [Member] | Level 1 [Member]

$ 9

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

International Pension Benefits [Member] | International common stocks [Member] | Level 1 [Member]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

International Pension Benefits [Member] | Fixed income securities [Member]

$ 0

Defined Benefit Plan, Assets, Target Allocations [Abstract]

International Pension Benefits [Member] | Fixed income securities [Member] | Level 2 [Member]

42.00%

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

International Pension Benefits [Member] | Equity index funds [Member] | Level 2 [Member]

^[1]

$ 0

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

International Pension Benefits [Member] | Emerging market equity index funds [Member] | Level 2 [Member]

^[2]

199

158

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

International Pension Benefits [Member] | Other common stock funds [Member] | Level 2 [Member]

^[2]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

International Pension Benefits [Member] | Fixed income funds: U.S. or foreign government and agency securities [Member] | Level 2 [Member]

^[2]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

International Pension Benefits [Member] | Fixed income funds: investment grade corporate bonds [Member] | Level 2 [Member]

^[2]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

International Pension Benefits [Member] | Fixed income funds: high yield corporate bonds and other [Member] | Level 2 [Member]

^[2]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

International Pension Benefits [Member] | Guaranteed investment contracts [Member] | Level 2 [Member]

^[2]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

International Pension Benefits [Member] | Real estate [Member] | Level 3 [Member]

^[3]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

Other Retiree Benefits [Member]

^[4]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

Other Retiree Benefits [Member] | Cash & cash equivalents [Member] | Level 1 [Member]

$ 32

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

Other Retiree Benefits [Member] | U.S. common stocks [Member] | Level 1 [Member]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

Other Retiree Benefits [Member] | International common stocks [Member] | Level 1 [Member]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

Other Retiree Benefits [Member] | Fixed income securities [Member] | Level 2 [Member]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

Other Retiree Benefits [Member] | Equity index funds [Member] | Level 2 [Member]

^[1]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

Other Retiree Benefits [Member] | Emerging market equity index funds [Member] | Level 2 [Member]

^[2]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

Other Retiree Benefits [Member] | Other common stock funds [Member] | Level 2 [Member]

^[2]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

Other Retiree Benefits [Member] | Fixed income funds: U.S. or foreign government and agency securities [Member] | Level 2 [Member]

^[2]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

Other Retiree Benefits [Member] | Fixed income funds: investment grade corporate bonds [Member] | Level 2 [Member]

^[2]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

Other Retiree Benefits [Member] | Fixed income funds: high yield corporate bonds and other [Member] | Level 2 [Member]

^[2]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

Other Retiree Benefits [Member] | Guaranteed investment contracts [Member] | Level 2 [Member]

^[2]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]

Other Retiree Benefits [Member] | Real estate [Member] | Level 3 [Member]

^[3]

Allocation of plan assets and level of valuation input for each major asset category [Abstract]